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Professor Erik D. Herzog, Chairperson

In mammalian hypothalamus, the suprachiasmatic nucleus (SCN) generates daily
behavioral and physiological rhythms as a circadian pacemaker. The 20,000 SCN
neurons synchronize to each other and to the ambient cues to generate coherent daily
rhythms. Vasoactive intestinal polypeptide (VIP), a neuropeptide produced by SCN
neurons, plays a major role in synchronizing SCN neurons to each other. Whether VIP
mediates synchrony to environmental cues and how synchrony within the SCN is
achieved has not been examined extensively. We recorded PERIOD::LUCIFERASE
(PER2::LUC) expression from SCN explant cultures over multiple days following VIP
application at different circadian time points to generate a phase response curve which
reliably predicted the phase relationship between the SCN and daily increases in VIP.
VIP shifted PER2::LUC rhythms in time- and dose-dependent manner. VIP rapidly
increased intracellular cAMP in most SCN neurons and simultaneous antagonism of
adenylate cyclase (AC) and phospholipase C (PLC) was required to block the VIP-
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induced phase shifts of SCN PER2 rhythms. We conclude that VIP entrains circadian
timing among SCN neurons through rapid and parallel changes in AC and PLC activities.

While performing the experiments mentioned above, we found that a single VIP pulse
reliably reduced the PER2::LUC rhythm amplitude in the SCN explants. The amplitude
reduction was dose-dependent, but not circadian. We found that the amplitude reduction
was primarily explained by reduced synchrony among SCN neurons, with little effect on
the amplitude of individual neurons. To test if VIP modulates the amplitude of circadian
rhythm in vivo, we compared the effects of light on locomotor rhythms in wild-type and
VIP-deficient mice. We found that constant light reduced the amplitude of behavioral
rhythms in wild type, but not in Vip-/-, mice. Because, theoretically, reduced synchrony
among oscillators can facilitate their entrainment to periodic signals, we tested if VIP
accelerates entrainment of animals to an 8-h advanced light-cycle or SCN explants to a
10-h advanced temperature cycle. We found that VIP doubled the speed of circadian
entrainment both in vivo and in vitro. We conclude that reduced synchrony by VIP
accelerates entrainment.

Finally, we characterized the spatiotemporal expression of one of the three major VIP
receptors, VPAC2R, in various brain areas and SCN. We characterized the specificity of
a new antibody and found moderate to weak levels of VPAC2R in cortex, hippocampus,
olfactory bulb, cerebellum, arcuate nucleus in hypothalamus, amygdala and ventrolateral
thalamus and high levels in the SCN. VPAC2R expression was observed from rostral to
caudal SCN with stronger expression in dorsomedial area. SCN neurons expressing VIP

iii

or vasopressin all expressed VPAC2R. We found intracellular VPAC2 expression mainly
along cell bodies and dendrites, but not along their axons. We found that VPAC2R levels
in the SCN do not oscillate in light-dark cycles or in constant conditions. We conclude
that VPAC2R presents broadly in the SCN throughout the day to mediate circadian
synchrony in the SCN.

Taken together, these experiments suggest that VIP signaling mediate entrainment to the
daily light cycle and an altered schedule by jet lag or day night shift work through wide
expression of VPAC2R in the SCN.
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Chapter 1.
Introduction

1

Properties of circadian rhythms
The day night cycle on Earth generates a temporal niche to all of its organisms. They
need to decide when to sleep, eat and avoid their predators. Circadian (from the Latin
circa – “about”, and dies – “day”) rhythms function to drive behavioral and physiological
oscillations following the 24-hour light dark cycle. These rhythms are innate in most of
organisms, persistent even in constant conditions with a period close to 24 hours, and
resistant to change their periods over a range of temperatures. Though circadian rhythms
persist with a period close to 24 hours even in the absence of timing cues, they
synchronize to cyclic timing cues via periodic adjustments (entrainment) (Pittendrigh &
Daan 1976b). The proper adjustments are vital to organisms’ health and survival
(DeCoursey et al. 1997). This applies to humans too, as shown in adverse effects of jet
lag and day night shift works on physical and mental dysfunctions (Cho 2001; Davidson
et al. 2006; Sahar & Sassone-Corsi 2007). This thesis addresses mechanisms regarding
the entrainment of the circadian system.

Circadian rhythms have been reported and described in multiple specifies ranging from
prokaryotes such as cyano- and proto-bacteria to eukaryotes including fungi, plants, and
animals (Sweeney & Hastings 1960; Pittendrigh 1967; Pittendrigh & Daan 1976b;
Czeisler et al. 1981; Kondo et al. 1993; Dunlap 1999). The existence of circadian
rhythms in diverse phylogenic trees, along with evolution, indicates beneficial aspects of
the coordination between biological timing processes and environmental fluctuations. In
the animal kingdom, for instance, circadian clocks play a role in optimizing animals’
adaptation to an ambient light dark cycle for their survival (Paranjpe et al. 2005), or
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guiding migrations of birds or butterflies by positioning the Sun’s location in the sky
(Froy et al. 2003). In human society, circadian rhythms affect well being of everyday life.
Modern affairs disrupting our circadian rhythms such as trans-meridian travels, day night
shift work, and day light savings are shown to cause lower efficiencies at work, cognitive
deficits, or even a variety of illnesses (Davidson et al. 2006; Czeisler & Gooley 2007). In
clinics, doctors are trying to find optimal time points of drug treatment based on our
circadian clocks (i.e. chronotherapy) (Yamamoto et al. 1997). It is still not clear how
circadian systems re-synchronize to advancing or delaying entrainment cycles.

The suprachismatic nucleus (SCN) as a master circadian pacemaker
In mammals, suprachiasmatic nucleus (SCN), one of the nuclei located in the ventral
hypothalamus, generates rhythms in physiology and behavior including sleep and waking,
feeding, excretion, blood pressure regulation, body temperature, locomotor activity, and
hormonal release (Moore et al. 1991). The bilateral nuclei are composed of about 20,000
neurons, located just above the optic chiasm and separated by the third ventricle.

Lesions of the SCN (Moore & Eichler 1972; Stephan & Zucker 1972; Ibuka et al. 1977;
Eastman et al. 1984; Schwartz & Zimmerman 1991) or electrical silencing in vivo
(Schwartz et al. 1987; Schwartz 1991) cause loss of rhythmicity in behavior and
physiology. SCN allografts to lesioned animals successfully restore rhythmicity in
behavioral rhythms with the period of donor SCN (Ralph et al. 1990). The restoration of
the rhythmicity may depend on direct neuronal connections and diffusible signals
(Lehman et al. 1987; Silver et al. 1990; Ralph & Lehman 1991). Therefore, the SCN is
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necessary and sufficient to generate circadian rhythms. The nature of these output signals
needs further examination, but several candidate molecules have been suggested
(Kalsbeek & Buijs 1992; Kramer et al. 2001; Cheng et al. 2002; Kraves & Weitz 2006).

The SCN shows daily rhythms in 2-deoxyglucose uptake (Schwartz & Gainer 1977),
cAMP and Ca2+ content (Murakami & Takahashi 1983; Ikeda et al. 2003), CREBmediated gene expression (Obrietan et al. 1999), electrical activity (Inouye & Kawamura
1979), neurotransmitter release (Schwartz & Reppert 1985) in vivo, and electrical activity
(Groos & Hendriks 1982; Shibata & Moore 1988; Herzog et al. 1996), neuropeptide
release (Shinohara et al. 1995; Watanabe et al. 2000), gene expression (Yamazaki et al.
2000) in vitro. These rhythms in various transcription factors, messenger molecules and
firing rate rhythms indicate the diverse, but orchestrated actions of the SCN to output
pathways as a master circadian pacemaker.

An intracellular clock mechanism
The advent of ‘clock genes’ arose in a relatively recent period from various species
including cyanobacteria, fungi, fruit flies, and mammals by genetic screens and discovery
of spontaneous mutations (Konopka & Benzer 1971; King et al. 1997; Ishiura et al. 1998;
Dunlap 1999; Emery & Reppert 2004). Though different species have different genetic
components, homologous mechanisms generate daily oscillations across species.
Fundamentally, the circadian clocks are composed of interlocking positive and negative
feedback loops, where a lag in transcription and translation generates near 24-hour
oscillations (Reppert & Weaver 2002; Emery & Reppert 2004). In mammals, a negative
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feedback loop inhibits the expression Period (Per1, 2 and 3) and Cryptochrome (Cry1
and 2) genes by their own protein products, PER and CRY. Per and Cry transcriptions
are activated by the binding of CLOCK and BMAL1 (Mop3) heterodimer complex on
their regulatory element, E-box (Gekakis et al. 1998). The accumulated PER and CRY
products, in turn, translocate into the nucleus, and repress the activity of CLOCK and
BMAL1. Subsequently, the reduction of PER and CRY level disinhibits CLOCK and
BMAL1 activity to increase Per and Cry transcription. Another negative feedback loop
inhibits Bmal1 transcription through the binding of REV-ERB to ROR-element (RORE)
of Bmal1 promoter (Ueda et al. 2002). A positive feedback loop activates Ror gene
through CLOCK and BMAL1, resulting in the increase of Bmal1 transcription by binding
of ROR to its RORE (Sato et al. 2004).

Genetic screens and findings of spontaneous mutations revealed the roles of clock genes
in the quality and speed of the rhythms. Single knockout of each gene except knocking
out Bmal1 does not abolish the rhythms completely, and animals show arrhythmicity in
constant darkness only when they lack Bmal1 or both Per1 and 2 or Cry1 and 2 (Kume et
al. 1999; Bae et al. 2001; Debruyne et al. 2006; Debruyne et al. 2007). Interestingly, the
knockout of Bmal1 leads to the decreased Bmal2 expression, which may mimic the effect
of knocking out the both genes (Shi et al. 2010). The phosphorylation of PER proteins by
a variety of kinases including casein kinase I epsilon facilitates degradation of PER, thus
it regulates the speed of the oscillations. Therefore, mutations in the kinase or
phosphorylation sites of PER lead to the lengthening or shortening of period in gene
expression and behavioral rhythms in flies (Lin et al. 2005), rodents (Lowrey et al. 2000;
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Meng et al. 2008), and human (Toh et al. 2001; Xu et al. 2005). Interestingly, a mutation
reducing the activity of an F-box protein, FBXL3 (Afterhours or Overtime) is shown to
lengthen the behavioral period through the stabilization of CRY proteins (Godinho et al.
2007; Siepka et al. 2007). The redundancy of gene components may improve the
precision of cellular rhythms or their stability against perturbations (Stelling et al. 2004).

Intercellular communication in the SCN
When SCN neurons lose intercellular communication, they fail to reliably generate
coherent gene expression or firing rate rhythms (Aton & Herzog 2005). If individual SCN
neurons contain the intracellular clock, why do they require the intercellular
communication? The research investigating roles of the intercellular communication
started recently since the development of two techniques: transgenic animals express
LUCIFERASE proteins driven by Period and the usage of cooled charged device camera
(Yamazaki et al. 2000; Yoo et al. 2004; Welsh et al. 2005). The imaging of the SCN
neurons from these transgenic animals using techniques for low-light imaging enabled to
visualize the roles of the communication. A chronic blockade of voltage gated sodium
channel by tetrodotoxin (TTX) treatment desynchronizes SCN neurons, leading to the
amplitude dampening of gene expression rhythms (Yamaguchi et al. 2003). Similarly,
SCN neurons plated in very low density show sloppy oscillations with a broad period
distribution (Webb et al. 2009). In a study using different circadian mutant SCN, the
coupling of SCN neurons is shown to overcome the genetic defects. The circadian gene
expression rhythms are intact in Per1-/- or Cry1-/- or Cry2-/- SCN explants, but their
SCN neurons lose rhythmicity (Per1-/- or Cry1-/-) or synchrony (Cry2-/-) when they are
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dissociated (Liu et al. 2007). Therefore, coupling or synchrony among SCN neurons
endows robustness to individual SCN neurons against perturbations. Indeed, the gene
expression rhythms in SCN slice cultures failed to entrain to a 6-hour temperature pulse,
or 20 hour- or 28 hour cycles initially, but entrained after the chronic treatment of TTX
(Abraham et al. 2010; Buhr et al. 2010). However, these results also suggest that the
reduced synchrony among the SCN neurons might be beneficial to entrainment to an
ambient cycle. This thesis investigates this possibility. Chapter 3 examines whether the
SCN or animals with reduced synchrony entrains more quickly to a largely advanced
light- or temperature cycle than synchronized ones.

Light effects of circadian rhythms
Periodic timing stimuli (i.e. light) entrain circadian rhythms within the range of
entrainment capacity (Pittendrigh & Daan 1976b). By entraining to the daily onset of
light, circadian pacemakers synchronize their period to the light cycle with a stable phase
relationship. Entrainment is achieved when the period of internal clocks (τ) is equal to the
period of the entraining stimulus (T; 24 hours in case of light), which requires daily phase
adjustments of circadian clock (ΔΦ: phase shifts) (Pittendrigh & Daan 1976b). Their
relation is as follows:
τ – T = ΔΦ
The direction and size of phase shifts by light depends on when the stimulus hit the
circadian clcoks, which is summarized in phase response curve (PRC). Assuming that the
light rapidly shifts the circadian rhythms (non-parametric entrainment), the PRC predicts:
1) what time the light stimulus need to be given for entrainment, 2) how many cycles the
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circadian clocks take to entrain, 3) a period range of the light stimulus to which a certain
period of circadian clocks is able to entrain and 4) phase angle of the entrainment
(Johnson et al. 2003). Indeed, evidence for non-parametric entrainment was demonstrated
in the eclosion rhythm of flies (Zimmerman et al. 1968), locomotor rhythm of nocturnal
rodents (Pittendrigh & Daan 1976b), in vitro oscillation of genes in cyanobacteria
(Yoshida et al. 2009). Although the SCN rapididly shifts in response to stimuli (Best et al.
1999), non-parametric entrainment has not been shown yet. Another goal of this thesis is
to demonstrate whether the SCN entrains to a repeated stimulus via rapid adjustments of
its phase. In chapter 2, we demonstrate the non-parametric entrainment of the PER2
expression rhythms in the SCN to repeated pulses of VIP, a neuropeptide expressed in the
SCN (An et al. 2011).

On the other hand, constant light or irregular light pulses (i.e. critical light pulse) appear
to affect the synchrony among circadian cells. Locomotor activity of hamsters or mice in
constant light for more than a month showed rhythms with a longer period or
arrhythmicity or two bouts of activity in a cycle (i.e. split) (Pittendrigh & Daan 1976a;
Ohta et al. 2005). Importantly, the SCN neurons from arrhythmic mice were
desynchronized, but the neurons from rhythmic ones remained synchronous (Ohta et al.
2005). A critical light pulse generates two desynchronized rhythms of gene expression in
rat SCN (Ukai et al. 2007), and arrhythmicity or rhythms with no amplitude in body
temperature, plasma cortisol in human (Jewett et al. 1991). It is not known what mediates
the light effects on split or arrhythmic behaviors or desynchrony among the SCN neurons.
In chapter 3, we find VIP reduces the synchrony among the SCN neurons, resulting in
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the amplitude reduction in their output rhythm, the behavioral rhythm (equal to the split
or arrhythmic behaviors) in constant light.

VIP signaling and its roles
VIP gene and biochemical properties. The Vip gene, encoding a 28-amino acid peptide,
is located on human chromosome 6p21-6qter (Gozes et al. 1987) and mouse chromosome
10 A1 (Lamperti et al. 1991). VIP belongs to the VIP peptide family with other
neuropeptides including the peptide with N-terminal histidine and C-terminal isoleucine
(PHI), pituitary adenylate cyclase activating polypeptide (PACAP), GH-releasing
hormone (GHRH), secretin, gastric inhibitory polypeptide (GIP), glucagon, and
glucagon-like polypeptide I (GLP-I) (Usdin et al. 1994). VIP and PHI are encoded by
two neighboring exons, and share the same precursor protein, but are processed by tissuespecific alternative splicing as shown in bird hypothalamus (Talbot et al. 1995). The
vicinity of its transcription start site contains cAMP-response element (CRE), raising the
possibility of its regulation by CREB (Fink et al. 1991). The Vip gene expression is
regulated by various factors including retinoic acid (Georg et al. 1994) and estrogen
(Kasper et al. 1992). The trigger mechanisms of the VIP release are not well-studied
except the NO-mediated release in enteric nervous system (Kim et al. 2003), or light- or
circadian release in the SCN (Shinohara et al. 1993; Shinohara et al. 1995).

VIP receptors and their biochemical properties. So far, the known VIP-binding
receptors are vasoactive intestinal polypeptide receptor 1 (VPAC1R, ~70 kDa),
vasoactive intestinal polypeptide receptor 2 (VPAC2R, ~60 kDa), and pituitary adenylate
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cyclase-activating polypeptide receptor 1 (PAC1R, ~50 kDa), which are encoded by
Vipr1 (~22kb), Vipr2 (30 kb), and Adcyap1r1 genes, respectively. They belong to
secretin family (class B) of Gs-protein coupled receptors (GPCR) with seventransmembrane helices (Langer & Robberecht 2007). GPCR is known to change its
conformation to interact with heterotrimetric G-proteins, and facilitate the exchange of
GDP to GTP on the Gα subunit upon its ligand binging. Generally, adenylate cyclase is a
known downstream pathway of these receptors through the Gαs, but couplings to
phospholipase C (PLC) and the calcium/InsP3 pathway through Gαq or Gαi is also
reported (Langer & Robberecht 2007). After binding to their ligands, VIP or PACAP,
VPAC1R and VPAC2R are rapidly phosphorylated (Langer et al. 2005), which promotes
the internalization through β-arrestin (Reiter & Lefkowitz 2006). The receptor regulation
may control the delivery and amplification of the signal from the ligand. VPAC1R
appears to be more sensitive to VIP and PACAP than VPAC2R (Usdin et al. 1994).
VPAC2R binds equally to VIP and PACAP, while PAC1R poorly interacts with VIP,
binding to PACAP preferentially (Christophe 1993; Lutz et al. 1993).

Functions and signaling in CNS and PNS. VIP modulates behavioral and physiological
functions acting through various brain areas. Its roles in circadian rhythms are covered in
detail below. It modulates neuronal firing in various brain areas such as the cortex
(Sessler et al. 1991), SCN (Reed et al. 2002), hippocampus (Yang et al. 2009), spinal
cord (Phillis et al. 1978), midbrain (Haskins et al. 1982), and locus coeruleus (Wang &
Aghajanian 1990). Also, it increases the communication of glia with neurons by
promoting secretion of cytokines and growth factors (Schettini et al. 1994). VIP is

10

involved in neurotrophic actions during the brain development (Gozes & Brenneman
1989) and after an injury in spinal cord, cerebellum, hippocampal and cerebral cortical
cultures (Brenneman et al. 1995; Cavallaro et al. 1996; Kim et al. 2005). In behavior, it
regulates sleep, and learning and memory. VIP, at least in part, is shown to increase REM
sleep by the involvement of prolactin release (el Kafi et al. 1995).VIP effects on learning
and memory differ (improve or deteriorate) with different locations, concentrations and
duration of the injection, thus its role is still in debate (Gozes et al. 1993; Yamaguchi &
Kobayashi 1994). Recently, humans with a microduplication in the Vipr2 gene show
higher chances of having schizophrenia (Vacic et al. 2011), indicating the relation of VIP
with psychological disorders.

The downstream components delivering VIP signaling are heterogeneous in different
brain areas. To modulate firing rates, VIP requires protein kinase A (PKA)-mediated
cAMP signaling in noradrenergic neurons of the locus coeruleus (Wang & Aghajanian
1990), but does not require it to depolarize retinal horizontal neurons (Lasater et al. 1983).
To promote the survival of neurons, VIP requires cAMP signaling in developing
sympathetic neuroblasts (Pincus et al. 1994), but requires protein kinase C not PKA in
postnatal mouse brains (Rangon et al. 2005). In the SCN, phase shift of neuronal firing
rate rhythms by VIP required PKA (Meyer-Spasche & Piggins 2004), while induction of
Period by VIP required PLC (Nielsen et al. 2002). Therefore, VIP uses different
downstream components at various brain areas depending on its functions, and if a novel
VIP action is known in a particular brain area, its downstream components may not be
the same with the already known ones. Chapter 2 identifies the downstream components
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of VIP-induced phase shifts in PER2 expression rhythms in the SCN. We found that only
simultaneous blockade of adenylate cyclase (AC) and PLC activities suppresses the VIPmediated phase shifts of gene expression rhythms. We conclude that VIP shifts circadian
rhythms in the SCN through parallel changes in AC and PLC activities in the SCN.
The roles of VIP in the PNS were not extensively studied, but some research suggests its
involvements in pain sensation (Payan & Goetzl 1988) or in pathogenesis in systemic
sclerosis (Matucci-Cerinic et al. 2001).

Expression profiles in the SCN. VIP-immunoreactivity is broadly observed in the SCN
(Romijn et al. 1997; Abrahamson & Moore 2001; Kalamatianos et al. 2004). VIP-ergic
neurons in ventrolateral SCN project their dense fibers throughout the SCN, mainly to the
dorsomedial SCN, where vasopressin-expressing (AVP-ergic) cells are located
(Abrahamson & Moore 2001). In the SCN, VIP-ergic neurons and AVP-ergic neurons
contribute to about 15 % and 20 % of total population respectively. The SCN shows a
strong Vipr2 mRNA signal, no, little if any, Vipr1 mRNA signal, and modest Adcyap1r1
mRNA signal (Usdin et al. 1994; Cagampang et al. 1998b; Kalamatianos et al. 2004).
With the slight difference between species, it is expected that approximately 30 % of VIP
neurons and about 60 % of AVP-ergic neurons express VPAC2R respectively
(Kalamatianos et al. 2004; Kallo et al. 2004). Since previous research detected the
VPAC2R expression with its mRNA probe or β-galactosidase driven by human Vipr2
promoter, it is not known the VPAC2R expression along neuronal projections, its
intracellular localization, and percentage of VPAC2R-positive neurons. These data will
identify the role of VPAC2 in synaptic transmission, and the number of neurons directly
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responsive to VIP. VIP-immunoreactivity in the SCN is not rhythmic in constant
condition, but rhythmic in diurnal condition, showing a decrease in the presence of light
(Shinohara et al. 1993). Whether and how VPAC2R is rhythmically expressed in the
SCN is not clear because of inconsistencies between research on its temporal mRNA
profiles (Cagampang et al. 1998c; Shinohara et al. 1999). Chapter 4 characterizes the
spatiotemporal expression of VPAC2R with a specific antibody against VPAC2R. We
found that VPAC2R is present in all SCN neurons throughout the day, overlaps with the
VIP and AVP expression, and functions in receiving synaptic information along dendrites
and cell bodies. We conclude that VPAC2R exists broadly in the SCN throughout the day
to mediate circadian synchrony in the SCN.

Roles in the SCN. VIP mediates circadian synchrony in the SCN. VIP is released from
retinorecipient VIP-ergic neurons by a photic stimulus, and conveys the photic
information to the SCN (Abrahamson & Moore 2001). Supporting this idea, behavioral
rhythms of animals lacking VIP (Vip-/-) or VPAC2R (Vipr2-/-) have aberrant phase angle,
different phase shifts and entrainment rates with light pulses or light dark schedules
(Harmar et al. 2002; Colwell et al. 2003). Animals lacking PAC1R do not have
significant deficits in their light responses, indicating that PAC1R is not essential in the
SCN (Hannibal et al. 2001). As the light transiently induces PER proteins (Field et al.
2000), VIP application induces Period gene transcription in SCN explant cultures
(Nielsen et al. 2002). Vipr2-/- mice failed to induce the Period genes after the photic
stimulation (Harmar et al. 2002). As an entraining agent like light, VIP application also
shifts behavioral (Piggins et al. 1995), firing rate (Reed et al. 2001), and AVP-release
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rhythms (Watanabe et al. 2000). However, this research has not identified whether VIP
entrains the SCN rhythms. In chapter 2, we generate a complete VIP PRC of PER2
expression rhythm, and entrain the PER2 rhythms by applying VIP daily as predicted by
our PRC. The resulting PRC is not identical to the light PRC (An et al. 2011).
Interestingly, the application of pigment dispersing factor, a functional homolog of VIP
in insects, generates a similar PRC about behavioral rhythms in cockroach to the VIP
PRC of PER2 expression rhythms, but not like light PRC (Petri & Stengl 1997). Since the
light regulates the levels of various neuropeptides and second messengers (Gillette &
Mitchell 2002), which applications also induce phase shifts of the SCN rhythms, we
conclude that VIP modulates the light-mediated phase shifts of PER expression rhythms
in an orchestration with diverse agents.

Another role of VIP is to generate and sustain synchrony among the SCN neurons. VIP
release is rhythmic even in constant conditions. Vip-/- mice were arrhythmic (60 % of the
total) or weakly rhythmic with multiple components in constant darkness or with daily
light pulses in 24 hour cycle (skeletal photoperiod) (Colwell et al. 2003; Aton et al. 2005).
Vipr2-/- mice showed similar behavioral defects in the same conditions (Harmar et al.
2002; Aton et al. 2005). In cellular level, the neurons from these mutants are arrhythmic,
or desynchronized each other if they are rhythmic (Aton et al. 2005; Maywood et al.
2006). Importantly, daily VPAC2R agonist treatments restore the rhythms and synchrony
among the Vip-/- SCN neurons (Aton et al. 2005). Therefore, VIP is necessary and
sufficient to generate rhythms of the SCN neurons and synchrony among them.
Surprisingly, we found that VIP application reduces the synchrony among the SCN, and
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investigateed the desynchronizing effect of VIP on the SCN in chapter 3. VIP
application reduces synchrony among the SCN neurons throughout the day in dosedependent manner, resulting in a decrease in amplitude of ensemble rhythms. This result
and previous research suggest that VIP switch its role from a synchronizing agent to a
desynchronizing agent depending on different doses (high dose: desynchronizing, low
dose: synchronizing) or situations (applied in coupled system: desynchronizing, applied
in uncoupled system: synchronizing). We conclude that VIP acts as a versatile agent,
which regulates synchrony in the SCN in different contexts.
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Chapter 2.
VIP entrains circadian oscillators

This chapter contains the manuscript:
An, S., Irwin, R. P., Allen, C. N., Tsai, C., Herzog, E.D. (2011) Vasoactive intestinal
polypeptide requires parallel changes in adenylate cyclase and phospholipase C to entrain
circadian rhythms to a predictable phase. J Neurophysiol.
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Abstract
Circadian oscillations in the suprachiasmatic nucleus (SCN) depend on transcriptional
repression by the Period (PER) 1 and 2 proteins within single cells and on vasoactive
intestinal polypeptide (VIP) signaling between cells. Because VIP is released by SCN
neurons in a circadian pattern and following photic stimulation, it has been suggested to
play a role in synchronization to environmental light cycles. It is not known, however, if
or how VIP entrains circadian gene expression or behavior. Here, we tested candidate
signaling pathways required for VIP-mediated entrainment of SCN rhythms. We found
that single applications of VIP reset PER2 rhythms in a time- and dose-dependent manner
that differed from light. Unlike VIP-mediated signaling in other cell types, simultaneous
antagonism of adenylate cyclase (AC) and phospholipase C (PLC) activities was required
to block the VIP-induced phase shifts of SCN rhythms. Consistent with this, VIP rapidly
increased intracellular cAMP in most SCN neurons. Critically, daily VIP treatment
entrained PER2 rhythms to a predicted phase angle within several days, depending on the
concentration of VIP and the interval between VIP applications. We conclude that VIP
entrains circadian timing among SCN neurons through rapid and parallel changes in AC
and PLC activities.
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Introduction
Coordinated rhythms across populations of neurons are believed critical to many
behavioral and cognitive functions (Buzsáki 2006). The mechanisms that synchronize the
periods of neural oscillators can include gap junctions which produce in-phase
rhythms(Schneider et al. 2006; Mancilla et al. 2007), reciprocal inhibition producing
either in-phase or anti-phase cycling(Wang & Rinzel 1992) and fast, weighted, excitatory
synapses producing a range of phase relationships(Smarandache et al. 2009). Daily, or
circadian, rhythms in behavior and physiology, however, depend on the neuropeptide,
vasoactive intestinal polypeptide (VIP). The mechanisms by which VIP synchronizes
circadian rhythms among cells are unknown.

The daily resetting of circadian timing establishes a stable phase relationship (i.e. the
phase angle of entrainment) between behavioral and physiological rhythms and
environmental cues. VIP is well-positioned to reset circadian oscillators in the brain to
each other and to exogenous timing cues. Vip and its receptors, Vipr1 and Vipr2, are
expressed in the central and peripheral nervous systems (Dietl et al. 1990; Mohney &
Zigmond 1998; Chaudhury et al. 2008) including in the suprachiasmatic nucleus (SCN),
a master circadian pacemaker (Cagampang et al. 1998c; Shinohara et al. 1999). VIP
applied to SCN explants in the late subjective night induces the transcription of Period
(Per) 1 and 2, two genes implicated in rhythm generation and entrainment (Nielsen et al.
2002). VIP can shift the daily rhythms in locomotion (Piggins et al. 1995) and in
electrical discharge (Reed et al. 2001) and vasopressin release (Watanabe et al. 2000) of
SCN explants. These actions of VIP in the SCN have been shown to depend on the

41

activities of phospholipase C (PLC) (Nielsen et al. 2002), adenylate cyclase (AC) or
protein kinase A (PKA) (Meyer-Spasche & Piggins 2004), but the signaling underlying
entrainment by VIP has not been studied.

A phase response curve (PRC) plots the steady state shift in a rhythm as a function of the
time of stimulation. The PRC can be used to predict features of entrainment including the
phase angle of entrainment, the range of periods to which the oscillator can entrain, and
how long it will take to entrain (Pittendrigh 1960). Importantly, existing PRCs have not
been tested for their ability to predict these features of SCN entrainment. This study
aimed to generate a PRC to VIP that would predict features of entrainment and could be
used to test the underlying molecular mechanisms and kinetics. We combined
pharmacology with recordings of bioluminescence from a reporter of PERIOD2 levels
and of Förster resonance energy transfer (FRET) from a reporter of cAMP levels. We
found that VIP directly entrains the PER2 rhythms of SCN neurons through rapid,
parallel changes in AC and PLC signaling.

Materials and Methods
ANIMALS. PERIOD2::LUCIFERASE (PER2::LUC) knock-in mice (Yoo et al. 2004)
(founders generously provided by J. S. Takahashi, Univ. of Texas Southwestern Medical
Center, Dallas, TX) were housed in a 12 h/12 h light/dark cycle and bred as homozygous
pairs in the Danforth Animal Facility at Washington University. All procedures were
approved by the Animal Care and Use Committee of Washington University or Oregon
Health Sciences University and followed National Institutes of Health guidelines.
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DRUGS. VIP was purchased from Bachem (King of Prussia, PA) or Tocris (Ellisville,
MO). MDL-12,330a (MDL), 9-(Tetrahydro-2-furyl)-adenine (THFA), 1-[6-[[(17b)-3methoxyestra-1,3,5(10)-trien-17-yl]amino] hexyl]-1H-pyrrole-2,5-dione (U73122),
forskolin and 3-isobutyl-1-methylxanthine (IBMX) were purchased from Sigma (Saint
Louis, MO). (7R)-4-Hydroxy-7-methoxy-N,N,N-trimethyl-3,5,9-trioxa-4phosphaheptacosan-1-aminium-4-oxide (Edelfosine) was from Tocris (Ellisville, MO).
Drugs were dissolved in DMSO or de-ionized water as stock solutions, stored at -20 °C
and diluted with culture medium so that the final DMSO concentration was below 0.4 %
of the total volume. Culture media consisted of DMEM (Sigma, Saint Louis, MO)
supplemented with 2% B27 (Invitrogen, Carlsbad, CA), 10 mM HEPES (Sigma, Saint
Louis, MO) and 2.2 mg/ml NaHCO3 (Invitrogen, Carlsbad, CA). VIP was dissolved in
culture medium and vehicle controls consisted of an equal volume of culture medium.

BIOLUMINESCENCE RECORDING. We recorded bioluminescence rhythms from 300
µm, coronal SCN slices from PER2::LUC mice (age 8-20 days) using a photomultiplier
tube (PMT) (HC135-11 MOD, Hamamatsu Corp., Shizuoka, Japan) as described (Abe et
al. 2002). SCN explants were cultured on 0.4 mm membrane inserts (Millipore, Billerica,
MA) in sealed 35-mm culture dishes (BD Biosciences, San Jose, CA) with 1 ml prewarmed air-buffered medium supplemented with 10% newborn calf serum (NCS)
(Invitrogen, Carlsbad, CA) and 100 μM beetle luciferin (Promega, Madison, WI) as a
final concentration at 34°C. Bioluminescence counts were integrated and stored at 1-min
intervals for up to 15 days of recording.
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During drug applications, 500 μl of the culture medium was mixed with the VIP,
antagonists or vehicle (culture medium, 5-50 μl) and added back to the culture dish. For
the phase shift experiments, circadian times were calculated in hours from the peak of the
PER2::LUC rhythm (CT 12) (Yoo et al. 2004). To minimize artifacts, treatments were
added without subsequent removal.

To measure the phase shift, Bioluminescence data were detrended by subtracting a 24-h
running average (Abe et al. 2002) and the daily peak of expression was determined using
an acrophase fitting function with Clocklab software (Actimetrics, Wilmette, IL). Phase
shifts were measured as the time difference between linear regressions of the acrophases
on the days prior to a treatment and the 4 to 5 days after treatment. In some cases, the
shift was measured after one to three cycles of transient shifts. Period of the PER2::LUC
rhythm was measured as the average time between acrophases from at least four days of
recording. The induction of PER2 expression was measured by averaging raw
bioluminescence signal of the cycle with the VIP or vehicle treatment. All statistics were
performed with Origin 7.0 software (Origin, Northampton, MA).

ELISA. We measured VIP concentrations to determine the profile of the neuropeptide
from 8 mouse SCN explants treated with either 1 µM VIP (n = 4) or vehicle (n = 4). We
collected 40 μl of medium from each culture 0, 10, 30, 60, 120 min, and 24 h after
treatment, froze at -35°C immediately and stored at -80°C. A competitive enzyme-linked
immunosorbent assay (ELISA) was performed according to the manufacturer’s protocol
(Peninsula Laboratories, San Carlos, CA). Absorbance was read at 450nm with a
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microplate spectrophotometer (Molecular devices, Menlo Park, CA). A standard curve
was generated with serially diluted standards ranging from 0 to 10 ng / ml and IC50 was
0.24 ng / ml.

cAMP MEASUREMENT. SCN cultures were prepared from neonatal Sprague-Dawley
rats and transfected with a cAMP reporter using the biolistic method as previously
described (Ikeda et al. 2003). Briefly, neonatal rat pups (3 - 7 days old) were decapitated,
the brains removed, and 200-300 µm thick coronal slices cut with a vibrating-blade
microtome (Camden Instr., Lafayette, IN). The slices were placed on Millicell-CM
membranes (30-mm diameter, 0.4 µm, Millipore, Billerica, MA) and maintained in an
incubator at 37 °C with 5% CO2. The organotypic cultures were grown in culture media
consisting of: DMEM/High without L-glutamine and with sodium pyruvate (Hyclone,
Thermo Scientific, Waltham, MA), 2% B27 supplement (GIBCO, Carlsbad, CA), 10 mM
HEPES (GIBCO, Carlsbad, CA), and 1X GlutaMax (GIBCO, Carlsbad, CA).

cAMP activity was measured using a fusion protein consisting of cyan fluorescent protein
(CFP), a truncated Epac1 expressing a cAMP binding site and yellow fluorescent protein
(YFP) (DiPilato et al. 2004a; Dunn et al. 2006a). The cDNA for ICUE2 was kindly
provided by Dr. Jin Zhang and Dr. Marla B. Feller (DiPilato et al. 2004a; Dunn et al.
2006a; Violin et al. 2008). A Helios Gene Gun (Bio-Rad Laboratories) was used
according to the manufacturer’s instructions to transfect the ICUE2 cDNA driven by a
CMV promoter, into 2- to 20-day-old cultures. Individual neurons were imaged between
2 and 7 days after transfection. Slice cultures were transferred to a recording chamber
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(35°C) with a laminar flow (6-8 ml/min) of an ACSF solution consisting of (in mM):
NaCl, 124; KCl, 2.5; NaH2PO4, 1.2; MgCl2, 1.2; CaCl2, 2.4; glucose, 10; NaHCO3, 24;
adjusted to 300 mOsm and bubbled with 5% CO2 and 95% O2. The recording chamber
was located on the stage of an inverted microscope (Nikon TE2000E, Toyko, Japan) and
illuminated using a xenon-arc lamp, passed through a 436/20 nm filter (Chroma, Tech.
Corp, Bellows Fall, VT) within a Lambda 10-3 filterwheel (Sutter Instruments, Novata,
CA) and with light reflected by a 455dcxru dichroic filter (Chroma, Tech. Corp, Bellows
Fall, VT). Images were visualized using an ORCA ER CCD camera (Hamamatsu
Photonics, Hamamatsu, Japan) after passing through a Dual-View beam splitter at
505dcxr (Optical Insights, Tucson, AZ), with 535/40 and 480/30 nm emission filters.
Data acquisition was controlled by Metafluor software (Molecular Devices, Sunnyvale,
CA) with binning and light exposure optimized to minimize photobleaching. The FRET
ratio, fluorescence at 535nm/480nm after background subtraction at each wavelength,
was normalized using the ratio before application of VIP. Neurons were identified by
morphological appearance. At the end of each experiment neurons were treated with
forskolin (20 µM) and 3-isobutyl-1-methylxanthine (IBMX, 75 µM). Cells that did not
respond were excluded.

STATISTICS. Comparison between two different groups with one variable was
performed using one-way ANOVA with a Scheffé post hoc test and comparison between
two different groups with two variables using two-way ANOVA with a Tukey post hoc
test. Values were considered significant if p < 0.05. All statistics and curve fits were
performed with Origin 7.0 (OriginLab, Northampton, MA).
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Results
VIP shifts of PER2::LUC rhythms depended on phase and dose.
We monitored the effects of 10 nM to 100 μM VIP on PER2-driven luciferase activity in
SCN explants. The half-life of VIP applied to SCN cultures was about 2 h based on
ELISA measurements (Fig. 1). VIP application near the peak of PER2 expression (CT12)
reduced the subsequent amplitude and delayed the peak of subsequent cycles compared to
vehicle-treated cultures (Fig. 2A). This manuscript focuses on the phase-shifting effects
of VIP, leaving cause and relevance of the amplitude effects for a subsequent analysis.
The steady-state phase shift after four days (Fig. 2B) was measured as a function of VIP
concentration (Fig. 2C). When applied at CT12, VIP induced a dose-dependent delay in
the peak of PER2 expression with a threshold around 100 nM (p<0.05 compared to
vehicle treated, One-way ANOVA, Scheffé post hoc, F1,15, =11.15), an EC50 near 500 nM
and saturation around 10 μM. VIP also induced a transient increase in PER2 expression
with a similar dose-dependence (Fig 2E). The threshold for VIP-mediated PER2
induction was around 100 nM, similar to the threshold for phase shifting (p<0.05
compared to vehicle treated, One way ANOVA, Scheffé post hoc, F1,6 =7.85; EC50 near
100 nM and saturation around 5 μM). Thus, a 10-fold increase in VIP concentration
approximately doubled the steady-state phase delay of SCN rhythmicity (r2 = 0.98, n =
30 SCN explants).

To measure whether VIP has phase-dependent effects on SCN rhythms, either 100 nM or
10 μM VIP was applied at various circadian time points. The resulting VIP phase
response curves (PRCs) had a large delay zone from early subjective day to early
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Figure 1. VIP added to the medium halved in concentration after 2 hours. The
percentage (black line) and concentration (grey line) of the remaining VIP in the culture
medium was measured using ELISA. After 2 hours, about half of the VIP remained and
only 20 % of VIP remained after 1 day.
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Figure 2. VIP phase shifted PER2::LUC rhythms in the SCN. (A) Representative
PER2::LUC traces with 10 μM VIP (black) or vehicle (gray) treatment at CT12 (arrow).
Each PER2::LUC rhythm was normalized to the peak prior to treatment. (B) Doubleplotted actograms of the bioluminescence traces from Fig. 1A where each line shows 48
h of data beginning with the last 24 h of bioluminescence from the line above. The
acrophase (black circle) of PER2::LUC expression was the daily peak of a sine function
fit to each cycle’s bioluminescence trace (Herzog et al. 2004). Phase shifts were
measured as the time difference between linear fits to the acrophases before and after the
treatment. (C) The dose-dependent phase delays induced by VIP applied at CT 12. Above
100 nM VIP and below 10 μM VIP, the delay of the PER2::LUC rhythm increased
linearly with logarithmic increases in VIP concentration. Data were fitted with a logistic
function (black line). (D) Phase response curves for 10 µM (square) or 100 nM (triangle)
VIP (n = 63 and n=33, respectively) as a function of circadian time of VIP application.
Phase delays and advances are displayed as negative and positive values respectively.
The PRC for 10 µM VIP was fitted with a fast Fourier transform, adjacent-point average
(line). Note that the PRC is dominated by delays and unlike the PRC to light. (E)
Concentration-response curve for the transient induction of PER2 by VIP. Data were
fitted with a logistic function (black line).
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subjective night (CT3-18) and a small advance zone from late subjective night to early
subjective day (CT19-1) with significant differences between the times of advances and
delays (p<0.01, F1,115 =7.11 , n =63, Two-way ANOVA, Tukey post hoc; Fig. 2D). VIP
(10 µM) treatments at CT11-12 induced a phase delay which was similar in magnitude at
one, two and three days following treatment (p=0.77, One-way ANOVA, F1,18=0.09). In
contrast, the same VIP treatment at CT19-23 induced advances which were larger when
measured the day after treatment than on subsequent days (p=0.02, One-way ANOVA,
F1,16=6.17; Fig. 3). VIP (10 µM) induced larger delays than 100 nM VIP at most of the
time points tested except the early subjective day. Vehicle treatment induced no or little
shift (p<0.05, Two-way ANOVA, Tukey post hoc, compared with 10 μM VIP, n= 41).
Therefore, adjustment of daily PER2 rhythms depended on the time of administration and
concentration of VIP.

Blockade of both AC and PLC activities was required to suppress VIP-induced
phase shifts.
Previous findings indicate that in the SCN, VIP may signal through cAMP- or Ca2+mediated pathways. We examined the effects of two inhibitors of AC and two inhibitors
of PLC on VIP-induced phase shifts. At the time of VIP administration , we included
MDL-12,330a (MDL), an irreversible, competitive inhibitor of AC (Lippe & Ardizzone
1991), 9-(Tetrahydro-2-furyl)-adenine (THFA), a noncompetitive inhibitor of AC
(O'Neill et al. 2008), U73122, an inhibitor of PLC (Smith et al. 1990), or (7R)-4Hydroxy-7-methoxy-N,N,N-trimethyl-3,5,9-trioxa-4-phosphaheptacosan-1-aminium-4oxide (edelfosine), a specific inhibitor of PLC (Powis et al. 1992). The VIP-induced
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Figure 3. VIP treatment during the late subjective night induced transient shifts of
PER2::LUC rhythms. (A) Representative actogram of PER2::LUC expression shows
that on the day after VIP application, the SCN rhythm was advanced by several hours (*)
and on subsequent days established a smaller steady-state phase shift (black line). (B)
Transient phase shifts were significantly larger than steady-state shifts following VIP
application around CT 20 (mean ± SEM; p<0.05, One-way ANOVA, F1,16=6.17), but not
at other times.
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Figure 4. VIP pulses rapidly changed the phase, but not the period of SCN cultures.
The period before and after 10 μM VIP treatment differed by less than 1 hour in most
SCN cultures (n=116 of 126). This is further evidence that VIP can entrain the SCN
through rapid shifts in the circadian oscillator.
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Figure 5. Blockade of cAMP and PLC signaling was required to reduce VIPinduced phase shifts. (A, B and C) Representative actograms of PER2::LUC rhythms
with treatment of 1 μM VIP alone, VIP with 2 µM MDL (inhibitor of AC) + 10 μM
U73122 (inhibitor of PLC), VIP with 100 µM THFA (inhibitor of AC) + 10 μM U73122
respectively. The inhibitor cocktails were applied 1 hour prior to the VIP application at
CT12. (D) The phase shift (mean ± SEM) of PER2::LUC rhythms by VIP applied at
CT12 was significantly attenuated by the combination of the AC and PLC inhibitors (*
p<0.05 and ** p<0.01, One-way ANOVA with Scheffé post hoc test). (E) In the absence
of VIP, the inhibitors induced little to no phase shifts (n = 25, when compared with
vehicle-treated cultures, p> 0.05). The number of cultures recorded is indicated for each
treatment.
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phase shifts of the PER2::LUC rhythms at CT12 were significantly reduced by the
combined application of MDL (2 μM) or THFA (100 μM) with U73122 (10 μM) or
edelfosine (10 μM) 1-h prior to VIP application (* p<0.05, F1,15 =8.47 for
MDL+U73122; ** p<0.01, F1,12=10.6 for THFA+U73122; ** p<0.01, F1,15 = 15.89 for
MDL+edelfosine, One-way ANOVA, Scheffé post hoc; Figs. 5A-D). None of the
inhibitors alone reduced the VIP-induced phase shift compared with VIP (p>0.05; Fig.
5D) or induced a significant shift compared with vehicle (p>0.05, One-way ANOVA,
Scheffé post hoc; Fig. 5E). The inhibitors alone or in combination also did not reduce the
amplitude of PER2 rhythms compared with vehicle. These results indicate that VIP
signals in parallel through AC and PLC to phase shift SCN rhythms.

VIP elevated cAMP in most SCN neurons.
To measure the responsiveness of individual SCN neurons to VIP, the cAMP reporter,
ICUE2, was transfected into individual SCN neurons (Fig. 6A). The ICUE2 and other
Epac-based FRET reporters detect increases in cAMP as a decrease in the YFP/CFP ratio
reliably in fly brain (Shafer et al. 2008), cultured retina (Dunn et al. 2006b),
hippocampus (Nikolaev et al. 2004), dorsal root ganglion (Murray et al. 2009), and
mammalian cell lines (DiPilato et al. 2004b; Nikolaev et al. 2004; Ponsioen et al. 2004).
To confirm the reliability of the ICUE2 in the SCN, we applied a combination of
forskolin (20 µM), an activator of most ACs and 3-isobutyl-1-methylxanthine (IBMX, 75
µM), an inhibitor of cAMP phosphodiesterase (PDE) to the ICUE2-expressing SCN
neurons at the end of each experiment. This treatment reduced the normalized FRET ratio
(Fig. 6A) within 4 min by 0.14 ± 0.02 ratio units in 21 neurons from 10 slice cultures.
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Application of VIP (1 μM) for 1 min reduced the FRET ratio in 10 SCN neurons in 4
slice cultures, consistent with a second messenger process (Fig. 6B and D). The duration
of the FRET response varied with some neurons returning to near baseline within 10 min
while others persisted longer than 20 min or as long as we recorded. Addition of THFA
(100 µM) to the bath 2 min prior to and during VIP application significantly reduced the
response of SCN neurons (measured 3 min after VIP, t13 = 3.88, p≤ 0.005 unpaired twotailed t-test, n = 11, 6 slice cultures, Figs. 6C, D) suggesting that intracellular VIP
signaling acts, at least in part, through the cAMP signaling.

VIP entrained the PER2::LUC rhythms to a predicted phase angle.
We investigated if and how the SCN circadian pacemaker might entrain to daily VIP
stimulation. Our VIP PRC predicted that daily VIP treatment should fall around CT2 to
entrain the SCN, approximately 10 h before the peak of PER2::LUC bioluminescence
(CT12). VIP (10 nM or 25 nM) or vehicle was applied to SCN cultures for 5 consecutive
days starting on the fifth day of the bioluminescence recording. The period of SCN
cultures was not altered by the vehicle treatment (before: 24.5 ± 0.3 h vs. during: 24.5 ±
0.2 h; n = 7 cultures, p = 0.97, One-way ANOVA; Figs. 7A, D). In contrast, the circadian
period was shortened by daily, 25 nM VIP with the bioluminescence peak occurring 10.1
± 0.4 h after VIP on the last day of application (period before: 24.7 ± 0.2 h vs. days 2-5 of
the treatment: 24.4 ± 0.2 h, n = 7 cultures; Figs. 7C, D). Notably, the phases of cultures
treated with 25 nM VIP were more synchronized (Rayleigh test, p < 0.05, r = 0.97) than
those of vehicle-treated cultures (p>0.1, r = 0.52; Fig. 7E). A lower dose of VIP (10 nM)
had a smaller effect on the period (before: 25.0 ± 0.3 h vs. during: 24.7 ± 0.2 h) and a less

56

Figure 6. VIP increased cAMP in SCN neurons. (A) A representative SCN neuron
expressing the ICUE2 reporter (inset image) showed a reduced FRET ratio
(535nm/480nm) after treatment with forskolin (20 µM) and IBMX (75µM), indicative of
increased intracellular cAMP. The data were normalized to the ratio at the initiation of
treatment. (B) Treatment with VIP (1 µM) reduced the FRET ratio in SCN neurons. Each
line represents a different neuron. (C) Pretreatment (2 min) with THFA (100 µM)
attenuated the VIP (1 µM)-induced reduction in the FRET ratio. (D) Plot of the mean ±
SEM responses to VIP (black, n = 10, Fig. 3B) and THFA + VIP (gray, n = 11, Fig. 3C)
showing that THFA treatment significantly reduced cAMP induction by VIP (unpaired
two-tailed t-test, * p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.005).
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Figure 7. VIP entrained PER2::LUC rhythms. (A, B and C) Representative actograms
of SCN PER2::LUC rhythms during five consecutive days of treatment (triangles) with
either vehicle, 10 nM VIP or 25 nM VIP. Note that the daily peak of PER2::LUC
rhythms shifted to follow the daily VIP pulse by approximately 10 h and free-ran from
that phase after the last VIP treatment. (D) The daily peak of PER2::LUC rhythms (mean
± SEM) of SCN cultures treated with VIP or vehicle (triangles) indicated that VIP
entrained circadian rhythms in the cultured SCN (vehicle, n=2; 10 nM VIP, n=3; 25 nM
VIP, n =3). Similar results were found in two additional replications of this experiment.
(E) Representative Rayleigh plots showing the phase angle of the PER2::LUC expression
(triangles) from cultures treated with vehicle (n = 7), 10 nM (n = 6) or 25 nM (n =7) VIP
on the fifth day of treatment. The time between the peak phase of the SCN cultures and
the time of treatment is the phase angle of entrainment. Note that cultures treated with
VIP had similar times of peak PER2::LUC bioluminescence whereas vehicle treated
cultures did not tend to peak at similar times. (F) The daily peak of PER2::LUC rhythms
(mean ± SEM) over 10 days showed that SCN cultures (open triangles) synchronized
their phase and period to 25 nM VIP applied every 25 h (filled triangles) for 5
consecutive days and free-ran (open circles) when treated with vehicle.
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reliable effect on the phase angle of entrainment (10.0 ± 1.1 h; n = 6 cultures; Figs. 7B,
D). Application of 25 nM VIP on a 25-h cycle also entrained the period of SCN cultures
(24.4 ± 0.1 h before and 25.0 ± 0.2 h during the application; n = 4 cultures) to the
predicted phase so that the VIP application fell 7.6 ± 0.7 h before the peak of
bioluminescence (Fig. 7F). In contrast, vehicle treatments every 25-h failed to change the
period (24.4 ± 0.2 h before versus 24.6 ± 0.1 h during; n = 2 cultures). Therefore, daily
VIP applications entrained PER2::LUC rhythms to the predicted phase angles.

Discussion
The mechanisms by which circadian rhythms synchronize to daily timing cues have been
formally described as a result of rapid changes in either phase or period of the
endogenous oscillator (Comas et al. 2006). Rapid phase adjustment, or non-parametric
entrainment, has been shown in the eclosion rhythm of flies (Zimmerman et al. 1968),
locomotor activity of nocturnal rodents (Pittendrigh & Daan 1976b), and in vitro
oscillation of cyanobacterial genes (Yoshida et al. 2009) and predicted for the SCN (Best
et al. 1999). Our results implicate VIP in rapid phase adjustment of the SCN on a daily
basis. Single pulses of VIP shifted the phase, rather than the period, of the SCN (Fig. 4)
and repeated pulses entrained SCN rhythms. Importantly, VIP doses near the threshold
for phase shifts, when applied daily, entrained circadian rhythms of PER2. VIP similarly
entrains circadian rhythms in cortical astrocytes (Marpegan et al. 2009). Thus, we
postulate that VIP shifts the oscillations of SCN cells through rapid changes in their clock
gene expression. In the SCN, VIP release is both circadian (Shinohara et al. 1995) and
increased by light (Shinohara et al. 1993; Shinohara et al. 1995). Based on the PRC
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measured here, we make two predictions: 1) increases in VIP release due to light during
the day delay SCN rhythms and, 2) in the absence of light, circadian release of VIP
peaking around midday delays free-running SCN rhythms. These predictions are
consistent with the advanced phase angle of entrainment in a light cycle and shortened
free-running period in constant darkness reported in VIP-deficient mice (Colwell et al.
2003).

The PRC to VIP described here is the first based on shifts in PER2 expression in the SCN,
differs in shape and amplitude from a PRC to light and also differs in some respects from
published responses to VIP. The PRCs for VIP-induced shifts in vasopressin and
multiunit firing rate rhythms were previously described as light-like with advances three
to eight times larger than the shifts reported here (Watanabe et al. 2000; Reed et al. 2001).
We found that advances were larger when measured on the day after VIP treatment (as
was done in previous studies) compared to the steady-state shift (Fig. 3). This illustrates
that the isolated SCN can exhibit large, transient adjustments in phase similar to what has
been described for behavioral shifts to light during the late night. Importantly, PRCs
based on the first day or two after a treatment can differ substantially from the steady
state PRC. By measuring the steady-state PRC to VIP applied at many different circadian
times from long-term recordings of SCN, we conclude the VIP PRC differs from the
effects of light in vivo or glutamate in vitro on SCN rhythms. The VIP PRC is dominated
by a large delay zone. Although this could be unique to PER2, it is consistent with the
period lengthening effects of chronic VIP infusion on locomotor activity (Pantazopoulos
et al. 2010).
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Interestingly, the PRC to VIP in the SCN shares a similar shape and amplitude as the
PRC to the neuropeptide, pigment dispersing peptide (PDF), in the cockroach (Petri &
Stengl 1997). PDF in flies appears to play roles similar to mammalian VIP in entrainment
and synchrony among circadian oscillators (Lin et al. 2004). Thus, the steady-state PRC
with a large delay zone and low amplitude, narrow advance zone may have features
which facilitate coordinated rhythmicity in populations of circadian cells.

The rate of entrainment and the phase angle of entrainment both depended on the
concentration of VIP and whether VIP was applied on a 24-h or a 25-h cycle. Thus, aging,
light intensity and other events which change VIP levels or time of release would be
expected to impact circadian behaviors. This is consistent with, for example, the
evidence that age-related changes in VIP timing and levels are intimately associated with
the menopause in rats (Krajnak et al. 1998; Gerhold et al. 2005). It is clear, however,
that VIP is not the sole entraining agent of the SCN since, for example, mice lacking VIP
or its receptor can still entrain to light cycles. Photic entrainment likely depends on
neuropeptides and transmitters including VIP (Piggins et al. 1995; Watanabe et al. 2000;
Reed et al. 2001), pituitary adenylate cyclase-activating polypeptide (Hannibal et al.
1997; Harrington et al. 1999), gastrin releasing peptide (Albers et al. 1995; Piggins et al.
1995; McArthur et al. 2000; Kallingal & Mintz 2006), glutamate (Meijer et al. 1988;
Ding et al. 1994; Asai et al. 2001) and NO (Ding et al. 1994) and intracellular signals
including cAMP (Prosser & Gillette 1989) and cGMP (Prosser et al. 1989; Liu et al.
1997).
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Although the exact sites of action for VIP-induced entrainment in the SCN are unknown,
we found VIP increased intracellular cAMP in individual SCN neurons (Fig. 6B). The
VPAC2 receptor, encoded by the Vipr2 gene, is presumed to be the primary mediator of
VIP activity since the loss of the receptor produces a phenotype similar to loss of VIP
(Harmar et al. 2002; Colwell et al. 2003). Consistent with our findings, Vipr2 mRNA
(Cagampang et al. 1998c; Shinohara et al. 1999) and a transgenic reporter using the
human Vipr2 promoter (Kallo et al. 2004) have been shown to be widely expressed in the
SCN.

We found convergence of VIP signaling to both the cAMP and Ca2+ signaling pathways
in the SCN. Previous reports have shown that prolonged blockade of cAMP production or
Ca+2 in the rodent SCN or snail retina stop the progression of circadian rhythms (Ralph et
al. 1992; Khalsa et al. 1993; Lundkvist et al. 2005; O'Neill et al. 2008). Here, low doses
of antagonists against cAMP and Ca+2 signaling suppressed VIP-induced shifts while
blockade of a single pathway had little effect on shifts. This implicates Gs in VIPmediated responses and also raises the possibility for the involvement of Gq or Gi/o
activities (Trimble et al. 1987; Van Rampelbergh et al. 1997; Gillette & Mitchell 2002;
Hains et al. 2004; Aton et al. 2006; Stewart et al. 2007) and suggests that at least two,
and possibly interconnecting, pathways are involved. Furthermore, the antagonists had
little effect on PER2 rhythms over 5-6 days, suggesting that the mechanisms mediating
shifts are more sensitive to cAMP and Ca+2 levels than the mechanisms involved in
rhythm generation. It is important to note that a subjective day (Prosser & Gillette 1989),
unlike our VIP PRC.
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Taken together, the findings presented here implicate VIP in the synchronization of SCN
neurons to each other and environmental cycles via increases in AC and PLC signaling to
rapidly shift clock gene rhythms.
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Chapter 3.
VIP accelerates entrainment of the SCN to an environmental cycle

This chapter includes the manuscript:
An S., Harang R., Meeker K., Granados-Fuentes D., Tsai C., Petzold L.R., Doyle III F.J.
Vasoactive intestinal polypeptide speeds circadian entrainment by reducing synchrony.
In preparation.
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Abstract
Shift work or travel across time zones can result in desynchronization of the body's
circadian rhythms from the local light-dark cycle. To date, there is no prevention or cure
for jet lag. In mammals, the suprachiasmatic nucleus (SCN) generates and sustains
circadian rhythms. In the SCN, about 20,000 neurons are coupled, and oscillate in
synchrony, generating high-amplitude rhythms. SCN cells depend on vasoactive
intestinal polypeptide (VIP) to synchronize to each other and to generate coordinated
circadian rhythms in physiology and behavior. We serendipitously found that VIP
reduced the amplitude of the PERIOD2 (PER2) ensemble rhythms in the SCN and
synchrony among SCN neurons in a dose-dependent manner. Consistent with our
findings in vitro, light-suppression of circadian rhythms in locomotor activity was
reduced in mice deficient for VIP. Based on properties of weakly coupled oscillators, we
hypothesized that reducing synchrony among SCN cells could facilitate synchronization
to environmental cues. We found that in vivo or in vitro delivery of VIP to the SCN
approximately halved the time required to entrain to an 8-10-h advance in the light or
temperature cycle. We conclude that treatments which reduce synchrony among the SCN
neurons can alleviate jet lag.
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Introduction
Circadian rhythms synchronize (entrain) to daily environmental cues such as light and
dark. In modern life, circadian oscillators in suprachiasmatic nucleus (SCN), a master
circadian pacemaker, entrain slowly following trans-meridian time travel or during shift
work. The long term misalignment between the internal timing and altered light dark
cycles can even induce physiological and psychological abnormalities including
depression, the risk of cancer, heart problems and obesity, and increased mortality (Cho
2001; Davidson et al. 2006). .
The neurons in the SCN synchronize to each other and to ambient oscillations of light. To
generate reliable oscillations in output rhythms and convey timing information
throughout the body, they require vasoactive intestinal polypeptide (VIP) signaling
(Harmar et al. 2002; Aton et al. 2005; Maywood et al. 2006). VIP is released in the SCN
as a function of circadian time and light intensity (Shinohara et al. 1994; Shinohara et al.
1995; Honma et al. 1998). In the absence of VIP (Vip-/-) or its receptor, VPAC2R
(Vipr2-/-), animals become arrhythmic with fragmented activity, and their SCN neurons
are arrhythmic or desynchronized each other (Harmar et al. 2002; Colwell et al. 2003;
Aton et al. 2005; Maywood et al. 2006). VIP application to the SCN explant cultures
induces Period (Per) 1 and 2 (Nielsen et al. 2002), two genes implicated in light-induced
resetting (Akiyama et al. 1999; Tischkau et al. 2000; Tischkau et al. 2003), and shifts
rhythms in behavior and SCN physiology (Piggins et al. 1995; Watanabe et al. 2000;
Reed et al. 2001; Meyer-Spasche & Piggins 2004; An et al. 2011). Notably, daily VIP or
VPAC2R agonist pulses entrain rhythms in SCN explants or Vip-/- SCN neurons (Aton et
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al. 2005; An et al. 2011). VIP has therefore been described as a synchronizer or coupling
factor in the mammalian circadian system.
Recent research suggests that desynchrony among or damping of individual oscillators
can promote entrainment. In entrainment experiments using temperature cycles or pulses,
the desynchronizing agents such as chronic tetrodotoxin treatment, a blocker of voltagegated sodium channels, or MDL-12,330a, a blocker of adenylate cyclase activity,
augment the entrainment of SCN slices (Abraham et al. 2010; Buhr et al. 2010). Since
the SCN is composed of about 20,000 circadian cells, the desynchrony leads to the
amplitude reduction of circadian rhythms in the whole SCN (Yamaguchi et al. 2003;
Abraham et al. 2010). This amplitude reduction in the whole SCN is, therefore, different
from the amplitude reduction due to the damping of individual neurons. Damped or weak
oscillators are predicted to be readily entrainable in a computer simulation and one
experimental result using Clock/+ heterozygote SCN (Vitaterna et al. 2006; Abraham et
al. 2010; Komin et al. 2011). However,it has not been examined, whether the
desynchrony or damping facilitates the entrainment to an entraining cue in vivo, and
whether a transient desynchrony among the SCN cells also promotes the entrainment.
Here, we report that VIP administration reduced the amplitude of ensemble PER2
rhythms and synchrony among SCN cells. The amplitude reduction of behavioral
rhythms by constant light depended, in part, on VIP. In addition, we found that VIP
administration in the early subjective day sped entrainment of circadian rhythms to an
advanced light- or temperatureschedule both in vivo and in vitro. These data suggest that

81

treatments which reduce the synchrony among the circadian oscillators will ameliorate
the negative consequences of jet lag or day night shift works.

Materials and Methods
ANIMALS. Mice were housed in a 12 h/12 h light/dark cycle in the Danforth Animal
Facility at Washington University. PER2::LUC knock-in mice (Yoo et al., 2004)
(founders generously provided by J. S. Takahashi, Univ. of Texas Southwestern Medical
Center, Dallas, TX) and Vip-/- (generous gift from C. S. Colwell, University of California,
Los Angeles, Los Angeles, CA) mice were backcrossed with C57BL/6 (purchased from
Charles River Laboratories), and bred as homozygous pairs. All procedures were
approved by the Animal Care and Use Committee of Washington University and
followed National Institutes of Health guidelines.

CULTURES. For recording of population rhythms, 300 μm coronal SCN slices from 8to 20-day-old PER2::LUC pups were obtained and immediately located under the
photomultiplier tube (PMT) (HC135-11 MOD, Hamamatsu Corp., Shizuoka, Japan).
Maintenance, recording of and VIP treatment of cultures were performed as described
previously (An et al. 2011).

For recording of single cell rhythms from slices, the coronal SCN slices were maintained
for 2-5 days on the 0.4 mm membrane inserts (Millipore, Billerica, MA) with 1 ml CO2buffered medium (CO2 DMEM) supplemented with 10 % new born calf serum (NCS)
(Invitrogen, Carlsbad, CA). Slices were then inverted onto poly-D-lysine (PDL) and
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laminin-coated glass coverslips and maintained for 6-8 days with 250-400 µl of the CO2
DMEM with the 10 % NCS until the recording.

DRUGS. VIP was purchased from Bachem (King of Prussia, PA). Culture media
consisted of DMEM (Sigma) supplemented with 2% B27 (Invitrogen), 10 mM HEPES
(Sigma) and 2.2 mg/ml NaHCO3 (Invitrogen). For in vitro recording, VIP was dissolved
in culture medium and vehicle controls consisted of an equal volume of culture
medium. For in vivo injection, artificial cerebrospinal fluid (aCSF) was used to dissolve
VIP.

BIOLUMINESCENCE RECORDING. We recorded bioluminescence rhythms from 300
µm, coronal SCN slices from PER2::LUC mice (age 8-20 days) using a photomultiplier
tube (PMT) (HC135-11 MOD, Hamamatsu Corp., Shizuoka, Japan) as described
previously (An et al., 2010). SCN explants were cultured on 0.4 mm membrane inserts
(Millipore, Billerica, MA) in sealed 35-mm culture dishes (BD Biosciences, San Jose,
CA) with 1 ml pre-warmed air-buffered medium supplemented with 10% newborn calf
serum (NCS) (Invitrogen) and beetle luciferin (Promega, Madison, WI) at 34°C.
Bioluminescence counts were integrated and stored at 1 min intervals for up to 15 days of
recording. To analyze the amplitude changes after VIP application, the recordings were
detrended as described previously (An et al. 2011). Then, the detrended traces were
divided by the peak prior to the application and top-to-bottom values of the each half
cycle were measured. To reduce the initial culture-to-culture variations, we divided each
value with an average of 2-3 cycles before the treatment. The display of bioluminescence
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traces and statistics were done using Origin 7.0 software (Origin, Northampton, MA)
unless mentioned otherwise.

SINGLE-CELL BIOLUMINESCENCE RECORDING. We recorded the
bioluminescence rhythm for single cells from slice cultures with an inverted microscope
(TI-S/L100, Nikon) and Andor iXon EMCCD (12 x 512 pixels, 16um pixel size) cooled
charged device camera (Andor technology) at -80 °C in 1 ml air-buffered medium with
luciferin and 10% NCS. Cultures were maintained in custom-built incubator (In Vivo
Scientific) at 34 °C.At the forth or fifth cycle, we applied 150 nM VIP or vehicle into the
culture medium and continued the recording for 4-5 days. Photon counts were integrated
over 1 minute or 10 minutes with Micro-Manager and processed with ImageJ (both
National Institute of Health). Cells clearly distinguishable from surrounding cells were
analyzed. To generate a raster plot using ImageJ, normalized data of the bioluminescence
traces was made by dividing with the peak prior to the application using detrending
macro (kindly provided by Dr. Marpegan). For the better contrast, these processed data
were subtracted by their trough value prior to the application so that the peak-to-trough
values are 1-0. Rayleigh statistics were done using Oriana (Kovach Computing Services,
UK).

MICROINJECTION. For stereotaxic surgery, mice were anesthetized with isofluorane
(Butler Animal Health Supply, Dublin, OH) mixed with continuous oxygen flow. Brain
was positioned flat along the Bregma to Lambda. A stainless steel guide cannula (4.0 mm,
26 gauge; Plastics One, Roanoke, VA) was inserted perpendicular to the skull, fixed with
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mixture of dental cement (CO-ORAL-ITE Dental MFG, Diamond Springs, CA) and
methyl methacrylate (Sigma, Saint Louis, MO). The coordinate for the SCN was from
Bregma: +0.5 mm posterior, +0.2 mm lateral, and +4.1 mm depth from the brain. 30 or
300 pmole of VIP (1.5 mM) or vehicle (aCSF) was injected with 200 nl volume in a
polyethylene tubing connected to 20 μl Hamilton syringe. The VIP or vehicle was
delivered using a microinjection pump (Model KDS 310, Analytical West Inc.) with the
flow rate of 50 nl / min.

BEHAVIORAL RECORDING. Adult male mice were housed in individual cages
established with running wheels and maintained in light-tight chambers with fluorescent
bulbs (General Electric). Locomotor activity was measured in 6 min-bin using Clocklab
(Actimetrics, Wilmette, IL). For measuring the light-induced VIP effect, the C57BL/6 (n
= 18) and Vip-/- (n = 15) mice were kept in constant light for about 40 days followed by
constant darkness for 10-11 days. For measuring the effect of VIP injection, 26 C57BL/6
mice were kept for 7 d in 12 h/12 h light/dark cycles, cannulated and recovered for
another 7 d followed by VIP (n = 14) or vehicle injection (n = 12). After the injection,
recording was resumed followed by light off. Recording was maintained for 13 days with
a light onset being advanced for 8 h. For better display purpose, a moving average with 4h time window was done in time series data of locomotor activity.

Results
VIP reduces the amplitude of PER2::LUC rhythm.
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As part of an analysis of VIP-induced phase shifts of the SCN (An et al., 2011), we
recorded PER2-driven bioluminescence from SCN explants treated with 10 nM to 100
µM VIP. We noted a highly reproducible and sustained reduction in SCN rhythmicity
following VIP (Fig. 1A). We measured the peak-to-trough amplitude 48 h after VIP
application and found a dose-dependent amplitude reduction in PER2 rhythms with an
EC50 near 150 nM and saturation above 10 µM (Fig. 1B). Within this range, a 10-fold
increase in VIP concentration caused a 50 % decrease in the PER2 amplitude (r2 = 0.99, n
= 31 explants). Following 1 μM VIP, the peak-to-trough amplitude was rapidly reduced
and then slowly recovered over approximately 9 days (Fig. 2). The amplitude reduction
was similar regardless of the time of VIP application (p > 0.05, F2,59 = 22.76, n = 74,
Two-way ANOVA; Fig. 1C).

VIP reduces the synchrony of SCN populations.
The amplitude reduction recorded from the population of SCN cells could reflect reduced
synchrony among SCN cells or reduced amplitude of individual cells (Fig. 3). To
distinguish between these possibilities, we monitored VIP effects on the PER2::LUC
rhythms in individual SCN neurons from a slice using an ultra-sensitive CCD camera.
Vehicle-treated SCN cells maintained their synchrony throughout the recording
(Rayleigh test, before vehicle: p < 0.05, r = 0.87, after vehicle: r = 0.84; Fig. 4A, B).150
nM or 10 µM VIP administration reduced the synchrony in individual neurons (Rayleigh
test, 150 nM VIP, before VIP: p < 0.05, r = 0.92 after VIP: r = 0.51; 10 µM VIP, before
VIP: p < 0.05, r = 0.74, after VIP: r = 0.37; Fig. 4C-F). The maintenance of synchrony in
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Figure 1. VIP reduced the amplitude of circadian rhythms in the SCN. (A)
Representative bioluminescence traces from SCN explants treated with 10 μM VIP
(black) or vehicle (gray) near the peak of PER2-driven bioluminescence (CT12, arrow).
Each PER2::LUC rhythm was normalized to the peak prior to treatment. (B) The dosedependent amplitude reduction (mean ± SEM; n = 3-5 cultures at each dose) by VIP
application at CT 12. Above 150 nM VIP and below 10 μM VIP, the amplitude reduction
of the PER2::LUC rhythm increased linearly with logarithmic increases in VIP
concentration. Data were fitted with a logistic function (black line). Amplitude was
measured as the trough-to-peak magnitude on the rising phase 48 h after VIP application.
(C) VIP application reduced the amplitude of SCN rhythms similarly at all circadian
phases. The amplitude reduction of PER2::LUC rhythm (mean ± SEM) was higher
following 10 µM VIP (squares) than 150 nM VIP (triangles; n = 20 and n = 16
respectively) at all times, but did not vary with the time of VIP application (p > 0.05,
F2,59 = 22.76, n = 74, Two-way ANOVA ). Vehicle (open circles) did not reduce the
amplitude of ensemble PER2 rhythm at any time.
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vehicle-treated culture and reduction of synchrony in VIP-treated culture was consistent
in multiple cultures (r value before vehicle: 0.93 ± 0.01, after vehicle: 0.91 ± 0.07, n = 2;
before 150 nM VIP: 0.84 ± 0.03, after 150 nM VIP: 0.51 ± 0.07, n = 5; before 10 µM
VIP: 0.77 ± 0.03, after 10 µM VIP: 0.25 ± 0.12, n = 2). Fold change in top-to-bottom
amplitude of individual cells with VIP administration was not significantly different from
that with vehicle application (p > 0.05, F1,750 = 3.2, One-way ANOVA, Scheffé post hoc;
Fig. 5). Therefore, ensemble PER2 rhythm by VIP can be explained by the reduced
synchrony among the SCN population.

VIP modulates circadian amplitude in vivo.
These in vitro results led us to test if VIP plays a role in modulating circadian amplitude
in vivo. Because prolonged constant light (LL) has been reported to desynchronize
rhythms among SCN cells and produce arrhythmic locomotor behavior (Ohta et al. 2005),
we recorded wheel running from wild-type (C57BL/6, n = 18) and VIP-deficient (Vip-/-,
n = 15) mice maintained in constant light (LL) for about 40 days . Time-series plots of
wild type mice showed a marked reduction of peak-to-trough amplitude in LL compared
to in DD (LL / DD ratio: 0.2 ± 0.04; Fig. 6A, C and E), while Vip-/- mice did not (LL /
DD ratio: 0.94 ± 0.17, ***: p < 0.0005, comparison of fold change in amplitude between
wild type and Vip-/- mice, One way ANOVA; Fig. 6B, D and E). Notably, 40 % of Vip-/mice even improved their circadian amplitude in LL, compared to in DD (6 out of 15).
Therefore, VIP plays a critical role in reducing the amplitude of locomotor activity
rhythms in response to light.
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Figure 2. The amplitude reduction by VIP was transient. The top-to-bottom
amplitude of PER2::LUC rhythm initially reduced by 1 µM VIP application at CT12
(black arrow), but gradually recovered back. Note that the amplitude of VIP- and vehicletreated rhythms is almost identical after 6 days (240 hours from the start of the recording)
from the VIP application.
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Figure 3. Damping or desynchrony may explain the amplitude reduction of
circadian rhythms in the whole SCN. Schematics assume that the whole SCN is
composed of three cells. (A) The amplitude of the rhythm in the whole SCN (a hot pink
line) is high because the three cells oscillate with high amplitude and in synchrony (gray,
pale pink, and sky blue line respectively). (B and C) The amplitude of rhythm in the
whole SCN reduces when the three cells are damping (B) or desynchronized (C).
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Figure 4. VIP reduced the synchrony among SCN cells. (A) PER2::LUC traces of 5
randomly selected cells with vehicle application (blue arrow) remained rhythmic and
synchronized so that the ensemble PER2::LUC rhythm of the slice (pink line) did not
change amplitude during the recording. (B) A raster plot shows the daily increase (green)
and decrease (black) in PER2 expression from 20 representative cells in the same SCN
slice treated with vehicle (yellow bar). Two Rayleigh plots show distribution of phases
among cells (n = 140) in this SCN on a day before and a day after vehicle administration,
respectively. Each dot represents the time of daily peak PER2 expression for one cell.
Note that the length of the mean vector (r) did not change following the treatment
indicating that the cells remained synchronized. (C) PER2::LUC traces of 5 randomly
selected cells with 150 nM VIP application at CT12 (blue arrow) remained rhythmic, but
their synchrony was reduced. Note that the gene expression rhythm amplitude of
individual cells was not reduced after VIP application. (D) A raster plot shows clear
reduction of synchrony of PER2 expression rhythm from 20 representative cells in the
same SCN slice with 150 nM VIP application at CT12 (yellow bar). Two Rayleigh plots
show that the length of the r was reduced after VIP application indicating cells are less
synchronized (n = 82). (E) PER2::LUC traces of 5 randomly selected cells with 10 µM
VIP application at CT2 (blue arrow) was not synchronized but their rhythm amplitude
was not. (F) A raster plot of 20 representative PER2::LUC traces and two Rayleigh plots
(n = 30) show clear reduction of synchrony after VIP application.
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VIP speeds up the entrainment of animals to changes in light schedule.
Our simulation results predict that VIP-induced reduction of synchrony could help the
animal to entrain faster to changes in light schedule. To test this possibility directly, we
implanted cannula (C57BL/6, n = 26) aimed at the SCN. After a week in a 12 h/12 h
light/dark schedule (light on from 7:00 am to 7:00 pm), mice received 20 or 200 pmole
VIP or vehicle (aCSF) at their Zeitgeber time (ZT) 3-4 (10:00-11:00 am). Light was off
briefly after that and on again at 11:00 pm corresponding to an 8 hr-advanced onset (light
on from 11:00 pm to 11:00 am). We chose to deliver VIP at ZT 3 as a time when it had
been shown to produce minimal shifts (Piggins et al. 1995; An et al. 2011). The animals
injected with VIP shifted rapidly their onset of activity and required fewer days to entrain
than the vehicle-injected animals (mean of VIP-injected animals: 2.93 ± 0.37 days, n =
14; vehicle-injected animals: 5.75 ± 0.83 days, n = 12, ***: p < 0.005, two sample
independent T-test; Fig. 7). These results suggest that VIP reduced the circadian
amplitude of the behavioral rhythm and sped entrainment following a large advance in
the light schedule.

VIP speeds up the entrainment of the SCN to changes in temperature schedule.
Next, we wanted to determine whether VIP also accelerates entrainment to the changes in
cycles of temperature cycle in the SCN level. To do this, we located SCN cultures in 12
h/ 12 h temperature cycle (at 6:00 am warm to 36.5 °C, at 6:00 pm cool to 35 °C) for 8
days. At the 8th cycles, we applied 10 μM VIP or vehicle at circadian time (CT) 3 (4:00
pm) to minimize the phase shift by VIP (An et al. 2011). 2 hours after lowering the
temperature at 6:00 pm, we raised the temperature at 8:00 pm to advance the cycle by 10
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hours (at 8:00 pm warm, at 8:00 am cool). The temperature oscillated with the schedule
for 9 days and stayed at 36.5 °C for 4 days. We assumed that an SCN culture entrains if
the peak PER2 expression has a stable phase relation for 48 h with the temperature cycle
and continued it until the end of the temperature cycle. SCN cultures with vehicle
treatment, took longer days to entrain to the 10h advanced temperature cycle than
cultures with VIP treatment (n = 5 each; Fig. 8). Notably, the phase of the peak PER2
expression in VIP-treated cultures were more clustered (mean phase: 17.23 ± 0.5,
Rayleigh test, p < 0.005, r = 0.8, n = 5) than vehicle-treated ones (mean phase: 12.57 ±
1.74, p >0.05, r = 0.25, n = 5) at the end of the new temperature cycle (day 18th). On
average, VIP-treated cultures entrained to the new temperature cycle after 4.2 ± 0.37 days
from the beginning of the advanced schedule while vehicle-treated cultures entrained
after 9.6 ±2.09 days (*: p < 0.05, two sample independent T-test, Figure 5F). Therefore,
together with the behavioral data these data suggest that VIP double the speed of the
entrainment to a new environmental cycle.

Discussion
We found that VIP accelerated the entrainment of behavioral rhythms of the animal and
PER2 gene expression rhythms of SCN explants (Fig. 7 and 8).This acceleration may be
explained by a phase advancing effect of VIP (Piggins et al. 1995; Watanabe et al. 2000;
Reed et al. 2001; An et al. 2011). VIP is known to shift PER2 gene expression rhythms in
the SCN and behavioral rhythms minimally in early subjective day (ZT or CT3-4)
(Piggins et al. 1995; An et al. 2011), when we applied VIP to the SCN cultures or
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Figure 5. VIP did not reduce the amplitude of PER2 rhythm in individual SCN cells.
A histogram shows the distribution of SCN cells according to their top-to-bottom
amplitude change. The amplitude was measured two cycles after the vehicle (gray) or
VIP (black) was divided with the amplitude before the treatment. If the fold change in
amplitude is smaller than 1, it means that the amplitude of a cell’s PER2 rhythm was
reduced after the treatment. Note that the distribution of the VIP-received cell
populations (n = 520 cells from 5 SCN slices) is similar to that of vehicle-received cells
(n = 232 cells from 2 SCN slices).
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Figure 6. VIP mediated the amplitude reduction of locomotor rhythms in LL. (A and
B) Representative actograms of wild type and VIP knockout (Vip-/-) mice kept in LL for
about 40 days (darkness shown as gray). Note that the wild-type mouse expressed
multiple daily peaks of activity compared to the more consolidated activity of the Vip-/mouse. Cage changes were done in days 32, 39, and 45. (C and D) Time series plots of
the same actograms reveal that the wild-type mouse showed low-amplitude rhythms in
LL and high amplitude rhythms in DD compared to the weak circadian rhythms in LL
and DD of the Vip-/- mouse. The bar at the bottom of each plot shows the times of lights
on (white) and off (gray). (E) The fold change in the peak-to-trough amplitude of daily
locomotion in wild-type animals was reduced dramatically in LL compared to DD, but
did not change in Vip-/- mice (mean ± SEM, n indicates the number of mice, ***: p <
0.0005, two sample independent T-test ).
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animals. Also, VIP reduced both the synchrony among the SCN and the amplitude of
ensemble gene expression rhythm throughout the day (Fig. 1), whereas VIP-induced
shifts showed large delays from mid-subjective day to late-subjective night and small
advances from late subjective night to early subjective day (An et al. 2011). Based on
these data, therefore, we conclude two things: 1) the faster entrainment by VIP is due to
the reduction of synchrony among the SCN population and 2) this acceleration can occur
throughout the day. Therefore, VIP effects, shown here, differ from the phase-dependent
acceleration of entrainment by sildenafil (Agostino et al. 2007) or long-term suppression
of aderenal corticosterone (Kiessling et al. 2010). The both treatments promoted the
entrainment in a phase advancing light schedule, but had no or worsening effect in a
phase delaying schedule.

VIP application reduced the synchrony among the SCN population and the amplitude of
gene expression rhythms in the whole SCN. In uncoupled cells such as astrocytes
(Marpegan et al. 2009) or Vip-/- SCN neurons (Aton et al. 2005), VIP augmented the
amplitude of ensemble PER2 rhythms and the synchrony among them. Therefore,
different coupling states may determine whether VIP application increases or decreases
synchrony. The intracellular action of VIP including PER induction (Nielsen et al. 2002;
Marpegan et al. 2009; An et al. 2011) or receptor internalization(Schulz et al. 2004;
Langer & Robberecht 2007) , may be possibly involved in this mechanism. Alternatively,
VIP action may depend on its concentrations. Wild type SCN cultures express and release
VIP into their medium, whereas astrocyte cultures or Vip-/- SCN neuronal cultures do not.
VIP may act as a synchronizing agent when there is little or noVIP whereas it may act as
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Figure 7. VIP accelerated the entrainment to phase-advancing entraining schedule
in vivo. (A and B) Representative actograms of vehicle- or VIP-injected mice followed
by an 8h-advance in light schedule. Animals were in 12 h/12 h light schedule for a week,
where light was on from 7 am. After an injection at ZT3-4 (arrow), the light onset was
advanced by 8 h (11 pm). Phase shift of behavioral rhythm and PER2 expression induced
by VIP at early subjective day is known to be minimal. Note that the vehicle-injected
mouse took longer days to entrain (the first entrained day: day 36th, asterisk, 8 days from
the injection day) while the VIP-injected mouse quickly entrained to the new light
schedule (the first entrained day: day 31th, asterisk, 3 days from the injection day). (C) A
group summary of daily activity onset of vehicle- or VIP-injected animals (mean ± SEM).
After the injection (arrow), the activity onset of VIP-injected animals (n = 14) shifted
more quickly following the 8 h advance in light schedule than that of vehicle-injected
animals (n = 12). Inset shows a group summary of days required to entrain to an 8hadvanced light schedule. VIP-injected group significantly entrained faster than vehicleinjected group (mean ± SEM, ***: p < 0.005, two sample independent T-test, VIPinjected group: 2.93 ± 0.37 days, n =14; vehicle-injected group: 5.75 ± 0.83 days, n = 12).
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Figure 8. VIP accelerated the entrainment to phase-advancing entraining schedule
in vitro. (A and B) Actograms of daily peak PER2 expression of SCN cultures with
vehicle- or 10 µM VIP application followed by a 10 h-advanced temperature cycle.
Initially, cultures were entrained to 12 h/12 h temperature fluctuations for 8 days (gray:
35 °C, white: 36.5 °C). At day 8, vehicle or 10 µM VIP was applied at CT3 (4:00 pm).
After becoming cool at 6 pm, temperature became warm at 8 pm to advance the
temperature cycle by 10 hours. The culture was assumed to entrain to the new cycle when
the phase for consecutive 4 days had a stable phase angle with temperature cycle. Note
that the vehicle-treated bioluminescence trace required 9 days to entrain to the new
temperature cycle (the first entrained day: day 17th, asterisk) while VIP-treated trace
quickly entrained (the first entrained day: day 13th, asterisk). The vertical line represents
days when these cultures had a stable phase relation with the temperature cycle. (C) A
group summary of daily peak phase of PER2 rhythm (mean ± SEM). White and gray
areas represent warm (36.5 °C) and cool (35 °C) temperature respectively. After the
treatment (arrow), all VIP-treated cultures (n = 5) drastically altered their phase, quickly
entrained to the new temperature cycle than vehicle-treated cultures (n = 5). Note the
bigger error bars in vehicle-treated case, indicative of poor synchrony among cultures.
Inset shows the days required to entrain in the vehicle- and VIP-applied groups. VIPapplied cultures entrained significantly faster than vehicle-treated ones (mean ± SEM, *:
p < 0.05, two sample independent T-test, VIP-injected group: 4.2 ± 0.37 days, n =5;
vehicle-injected group: 9.6 ± 2.09 days, n = 5).
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a desynchronizing agent with the large amount of VIP. This idea is also supported by the
dose-dependency of synchrony reduction (Fig. 4) and the increased amplitude of
ensemble gene expression rhythm with 10-50 nM VIP application (Fig. 1B).

We also found that VIP modulates the reduction of behavioral rhythm amplitude in LL.
Top-to-bottom amplitude of behavioral rhythm of wild type animals dramatically reduced
at the end of LL but that of Vip-/- did not (Fig. 6). Since the reduced synchrony among
the SCN neurons caused the amplitude reduction of circadian rhythms in the whole SCN,
and the SCN generates output rhythms, the amplitude reduction in behavioral rhythms
might be caused by the reduced synchrony in the SCN. Notably, LL appears to have the
similar effects with VIP. In LL, some of mice become arrhythmic, and their SCN neurons
are desynchronized (Ohta et al. 2005). In addition, mice in LL for only one day show a
big shift in behavioral rhythms by 15 hours, which may facilitate to entrain to an altered
entraining cycle (Chen et al. 2008). Therefore, we expect that illumination by a strong
light before a travel would be an alternative way to alleviate jet lag.

Interestingly, 40 % of our Vip-/- mice became rhythmic at the end of LL protocol (Fig. 5).
We assumed that a secondary synchronizing agent may act to drive rhythmicity only in
LL without VIP. Notably, it was shown that elevated K+ concentration or gastrin
releasing peptide (GRP) temporarily restored the PER2 gene expression rhythms from
Vipr2-/- SCN explants (Maywood et al. 2006). Thus, it is intriguing to test whether
potassium chloride (KCl) or GRP injection temporarily recovers the synchrony in Vip-/or Vipr2-/- animals, and the synchrony among the SCN neurons is actually improved in
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these rhythmic animals. Alternatively, external or internal noises such as routine cage
changes or little fluctuations in light intensity or gene expression might have induced
spontaneous behavioral rhythms in Vip-/- animals at the end of LL. One simulation
predicts the emergence of synchrony from arrhythmic population with noise in light
illuminations(Ullner et al. 2009). Also, noise in gene expression is suggested to drive the
irregular circadian rhythms of PER2 expression in Bmal1-/- SCN explants, which is
thought be arrhythmic (Ko et al. 2010). Like the simulation showing the role of the noise
in Bmal-/- SCN, simulations reconstructing the emergence of rhythmicity in behavior of
Vip-/- animals would provide valuable information to the circadian researchers.

Taken together, we revealed that VIP addition leads to faster entrainment via reduction in
synchrony among SCN population and in theamplitude of ensemble gene expression in
the SCN. Future works will focus on categorizing the SCN cells depending on their
response to VIP to understand the VIP actions in detail. We conclude that VIP facilitates
the entrainment by reducing synchrony among the circadian oscillators in the SCN, and it
can be used as a potential therapy for jet lag and day night shift works.
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Chapter 4.
Spatiotemporal distribution of VIP receptor, VPAC2R in the SCN

This chapter includes the manuscript:
An S., Tsai C., and Herzog E.D. Spatiotemporal distribution of VIP receptor, VPAC2 in
the SCN. In preparation.
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Abstract
The suprachiasmatic nucleus (SCN) in the hypothalamus is a master circadian pacemaker
in mammals. The SCN neurons must synchronize each other and to the ambient
entraining cues to coordinate daily rhythms in physiology and behavior. Vasoactive
intestinal polypeptide (VIP) and its major receptor in the SCN, vasoactive intestinal
polypeptide receptor type 2 (VPAC2R) play a role in maintaining circadian synchrony as
coupling factors. It is unknown where and when VPAC2R expression exists in the SCN.
It has been predicted based on mRNA and transgene expression that VPAC2R may be
expressed rhythmically and in a subset of SCN cells. Here, we examined VPAC2R
abundance using a specific antibody. VPAC2R was expressed broadly in the brain and
most highly in the SCN with stronger expression in dorsomedial area of the rostral and
medial SCN. VPAC2R immunoreactivity heavily overlapped with AVP and VIP cells in
the SCN and was mainly observed along dendrites and cell bodies, but not along axons.
This regional localization and signal intensity did not change with time of day in a12 h/12
h light/ dark or in constant darkness. These results suggest that VPAC2R mediates
circadian synchrony throughout the day via broad, constitutive expression in the SCN.
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Introduction
The suprachiasmatic nucleus (SCN) acts as a master circadian pacemaker generating
various physiological rhythms in mammals. Though individual SCN neurons harbor cellautonomous feedback machinery, they depend on neuropeptides to reliably express the
clock genes (Yamaguchi et al. 2003; Aton et al. 2005; Maywood et al. 2006).
Neuropeptides and their efferent projections play a major role in synchrony among SCN
neurons, conveying photic information and coordination of SCN with the rest of the body
(Vosko et al. 2007).

Previous research suggests the roles of VIP-VPAC2R in circadian synchrony by
conveying timing information. VIP is released rhythmically in constant conditions, and
its release is stimulated by light (Shinohara et al. 1993; Shinohara et al. 1995). Animals
lacking VIP (Vip-/-) or VPAC2R (Vipr2-/-) have defects in rhythm generation. They
show fragmented locomotor activity in constant conditions (Harmar et al. 2002; Colwell
et al. 2003; Aton et al. 2005) and arrhythmic body temperature, hormonal release, and
heart rate (Loh et al. 2008; Schroeder et al. 2011). In the SCN, neurons are arrhythmic or
lost synchrony among them in firing rate and gene expression rhythms (Aton et al. 2005;
Maywood et al. 2006). These results suggest that the VIP-induced rhythm generation of
and synchrony among the SCN neurons is critical to generation of rhythmic behaviors.
Loss of VIP signaling also impairs the delivery of light information in the SCN. Vip-/- or
Vipr2-/- mice have aberrant responses to light including the smaller phase shift and
altered phase relation with light (Harmar et al. 2002; Colwell et al. 2003). Vipr2-/- mice
fail to induce gene expressions following light stimulus, for instance, Period (Per), c-
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FOS, and phosphorylated extracellular signal-regulated kinases 1/2 (Harmar et al. 2002;
Hughes et al. 2004). Importantly, VIP entrains in vitro and phase shifts the PER2 gene
expression and firing rate rhythms (Reed et al. 2001; An et al. 2011). Therefore, VIP may
mediate circadian communication and synchrony by the rhythmic release into the SCN,
ability to entrain the SCN, and requirement for the rhythmic behaviors. It is not known
how and when VIP acts to synchronize SCN neurons.

Vasoactive intestinal polypeptide (VIP), a 28-amino acid neuropeptide is a candidate
synchronizing factor. In the SCN, cells in the ventrolateral area generate VIP and project
mainly to the dorsomedial SCN, where arginine vasopressin (AVP) cells are located. The
wide distribution of VIP projection in the SCN suggests their direct communication with
all SCN cells. VIP binds to secretin receptor family (class B) of G-protein coupled
receptor (GPCR), which includes vasoactive intestinal polypeptide 1 (VPAC1R),
vasoactive intestinal polypeptide 2 (VPAC2R), and pituitary adenylate cyclase-activating
polypeptide type 1 receptor (PAC1R). mRNA signal of all three receptors are widely
expressed throughout the brains (Usdin et al. 1994). In the SCN, however, a strong
VPAC2R mRNA signal, moderate PAC1R mRNA signal, and no VPAC1R signal is
present (Usdin et al. 1994; Cagampang et al. 1998c; Kalamatianos et al. 2004).
Biochemical studies reveal that PAC1R preferentially binds to pituitary adenylate
cyclase-activating polypeptide to VIP (Vosko et al. 2007). Therefore, VPAC2R appears
to mainly mediate VIP signaling in the SCN.
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VIP peptide and VPAC2R mRNA expression exhibit a juxtaposed pattern in the SCN.
VIP-ergic neurons are mainly located in ventrolateral area, which receives photic inputs
directly from intrinsically photosensitive retinal ganglion cells (Kalamatianos et al. 2004;
Hattar et al. 2006). VIP-ergic neurons project their dense fibers throughout the SCN,
especially the dorsomedial area, where vasopressin-expressing (AVP-ergic) neurons are
located (Abrahamson & Moore 2001). mRNA profile of VPAC2R (Kalamatianos et al.
2004), binding assay with a VPAC2R-specific agonist (Harmar et al. 2002) and
exogenous expression of β-gal driven by human VPAC2R promoter (Kallo et al. 2004)
implicate its main expression in the dorsomedial SCN. The β-gal expression overlaps
with ~50 % AVP-ergic cells and ~30 % VIP-ergic cells (Kallo et al. 2004). Though the
mRNA and transgene results raise interesting insights about VPAC2R, they have not
identified critical information yet. For instance, it is not known whether VIP acts as a
paracrine signal by crossing synapses or an endocrine signal to travel large distances.

Since VIP signaling generates rhythmic behaviors, it is intriguing whether VPAC2R
oscillates in the SCN in a circadian day. Previous results of the temporal Vipr2
expression show, at least, diurnal oscillations, but are not consistent each other. In lightdark (LD) cycle, VPAC2R mRNA peaks at the late subjective night only (Shinohara et al.
1999) or at the late subjective day and night (Cagampang et al. 1998c). In constant
darkness (DD), the expression may show no rhythm (Shinohara et al. 1999) or peaks at
late subjective day and night (Cagampang et al. 1998a). Although we assume that
VPAC2R is rhythmically expressed in the SCN following the mRNA profile, the
temporal profile of VPAC2R can be different from that of Vipr2. For instance, the PER2
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gene expression rhythm is about 6 hour delayed than its mRNA rhythm (Field et al.
2000). A recent VIP PRC of PER2 expression rhythm exhibits that the SCN responds to
VIP differently at different time of the day, suggesting the circadian regulation of amount,
or, at least, properties of VPAC2R such as intracellular localization, affinity to the VIP.

Here, we characterized expression profile of VPAC2R in the SCN with a specific
antibody (Schulz et al. 2004). We found moderate to weak VPAC2R expression in
various brain areas and strong expression in the SCN. We found VPAC2R expression
from rostral to caudal axis with more intensive expression in dorsomedial area.
Consistent to this finding, an intense overlap of VPAC2R expression with AVP-ergic
cells and VIP-immunoreactive cells or projections was observed. Intracellular expression
of VPAC2R was mainly along cell bodies and dendrites not along axons. We found that
VPAC2R expression does not oscillate in circadian or diurnal manner. We conclude that
VPAC2R presents broadly in the SCN throughout a day to mediate circadian synchrony
in the SCN.

Materials and Methods
ANIMALS. Male C57BL/6 mice, VPAC2R knockout mice (Vipr2-/-),
PERIOD2::LUCIFERASE knockin (PER2::LUC) mice were housed individually in 12
h/12 h light/ dark cycle. For the experiments in DD, animals were transferred to lighttight, ventilated chamber for 2 days. All procedures were approved by the Animal Care
and Use Committee at Washington University and conformed to National Institutes of
Health (NIH) guidelines.
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TISSUE PREPARATION. For the circadian measurement, 40 Animals were housed in
12 h/12 h LD or DD before perfusion at 6 different zeitgeber time (ZT) or circadian time
(CT) respectively. After anesthesia with 2.5 % avertin, animals were perfused
intracardially with 0.9 % saline followed by 4 % paraformaldehyde (PFA) solution.
During the period without a light (ZT12-24 and CT), anesthesia and perfusion were done
in the dim red light. Brains were kept in the PFA solution for 24 hours, then transferred to
30 % sucrose phosphate buffered (PBS) solution for 3 days until the brains sunk. Brains
were quickly frozen with 2-methylbutane maintained at -35 °C and stored at -80 °C for
further usage. 6 series of coronal sections were obtained with a cryostat (CM1850; Leica,
Maryland Heights, MO) and stored in Watson’s cryoprotectant solution, pH 7.2, at -20 °C
at least for 48 hrs before proceeding immunohistochemistry. For the analysis of
intracellular localization, dissociated SCN neuronal cultures were used. SCN punches
were taken from coronal hypothalamic slices of C57BL/6 pups (p1-5) and cells were
digested with papain at 37 °C for 40 minutes. After brief centrifugation, papain solution
was replaced with media and cells were triturated by gentle pipetting. Cells were plated
on a poly-D-lysine (Sigma, Saint Louis, MO) and laminin (Sigma, Saint Louis, MO)covered glass coverslip with a density of 3,000 cells / mm2. After a week from the
surgery, cells were fixed with chilled 4 % PFA solution for 15 minutes.

IMMUNOSTAINING.
1. Co-staining of VPAC2R with VIP/ AVP or axonal/dendritic marker
Series of free-floating sections or cell cultures were rinsed with PBS three times followed
by incubation with 3 % Triton X for 30 minutes at 37 °C. After wash with PBS, samples
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were incubated with blocking solution (10 % non-fat milk, 10 % BSA, 0.015 % Tween20) for 1 h at room temperature followed by addition of 1: 1,000 rabbit anti-VPAC2
antibody (AbCam). Then, samples were incubated with 1:200 donkey anti-rabbit Cy2 for
2 h at room temperature. For double-staining with VPAC2R antibody, samples were coincubated with 1:50 mouse anti-AVP antibody (a gift from Dr. H. Gainer) or 1: 2,000
chicken anti-MAP2 antibody (dendritic marker, AbCam) or 1: 2,000 mouse anti-Tau1
antibody (axonal marker, Millipore) overnight at 4 °C. In case of a double-staining using
antibodies raised from the same species, two separate immunostainings were performed
to prevent cross talk. Samples were sequentially incubated with VPAC2R antibody,
1:200 donkey anti-rabbit Cy2, and then incubated with 1: 2,000 rabbit anti-VIP antibody
(Immunostar), 1:200 goat anti-rabbit Cy3. At the end of the staining, every sample was
incubation with 4',6-diamidino-2-phenylindole (DAPI) for 10 minutes to distinguish the
boundary of the SCN. Sections were mounted on slides (12-550-14; Fisher Scientific),
dried overnight, and coverslipped with Permount (SP15-500; Fisher Scientific). In each
experiment, SCN-containing sections from VPAC2 knockout mice and sections without
the incubation of primary antibody were used as negative controls.

2. Staining for VPAC2R as a function of time of day
After permeablization with Triton X and washes, series of sections collected at different
ZTs or CTs were incubated with 10% H2O2 in PBS at 4 °C for 30 minutes. Sections were
washed with PBS, blocked for 1 h and incubated with 1:15,000 anti-VPAC2R antibody at
4 °C for 2 days with agitation. Following 3 time wash in PBS, sections were incubated
with 1:200 biotinylated goat anti-rabbit antibody (Standard ELITE ABC kit, Vectastatin,
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Vector labs, Burlingame, CA) at 4 °C for 1 h. Then, sections were incubated with an
avidin-biotin complex (Vector Labs). Sections were rinsed 3 times with PBS, rinsed with
50 mM Tris-HCl, and then incubated for 10 minutes with 0.05 % 3,3’-diaminobenzidine,
0.01 % H2O2, 0.03 % NiCl2 in 50 mM Tris-HCl. Sections were rinsed with PBS
overnight, and wet mounted onto glass Superfrost slides (Fisher) the next day. The
mounted sections were dehydrated in series of ethanol and xylene solutions.

IMAGE PROCESSING. Digitized images were taken using an epifluorescent microscope
(Retiga 1350EX; QImaging, Burnaby, British Columbia, Canada), or a confocal
microscope (Nikon A1, Imaging core, Department of Biology), or slide scanner
(Nanozoomer Digital Pathology, Hamamatsu, Alafi NeuroImaging Laboratory,
Department of Neurology) under the fluorescent or bright light illumination. For
brightness and contrast, the images were processed with ImageJ (NIH, Bethesda, MD).
To quantify the circadian intensity of VPAC2R expression, pixel intensity of VPAC2R
immunoreactivity was averaged in the bilateral SCN area after being subtracted from the
background (brain areas outside of the SCN).

DATA ANALYSIS. Day and night difference of VPAC2R expression was assessed by
one-way ANOVA with a Schéffe post hoc (Origin 7.0, OriginLab, Northampton).

Results
Specificity of the VPAC2R antibody
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We tested the specificity of three antibodies against VPAC2R: rabbit anti-VPAC2R
(antibody generated using C-terminus of VPAC2R, AbCam), goat anti-VPAC2R
(SantaCruz), mouse anti-VPAC2R (antibody generated using N-terminus of VPAC2R,
AbCam) by a comparison between wild type and Vipr2-/- brain sections. The rabbit antiVPAC2R showed an intense staining on the wild type SCN but not on the Vipr2-/- SCN
above the background staining (Fig. 1). The other two antibodies had almost equal
intensity of staining in both wild type and Vipr2-/- SCN (data not shown). We concluded
that only the rabbit anti-VPAC2R specifically recognizes the VPAC2R among them and
used it for further study.

VPAC2R levels were highly abundant in the SCN.
We found a strong VPAC2R expression in the SCN along the rostral to caudal axis (Fig.
2). In middle to rostral sections, VPAC2R immunoreactivity was higher in dorsomedial
area. We also detected moderate to weak VPAC2 expression in various brain areas
including hippocampus, indusium gresium, olfactory bulb, and arcuate nucleus (Fig. 1) of
hypothalamus, bed nucleus of the stria terminalis (BNST) in the amygdala, ventrolateral
thalamus, and cerebellum. Thus, VPAC2R was expression throughout the brain with the
highest intensity in the SCN.

VPAC2R was detected in VIP and AVP neurons.
We examined if VPAC2R expression overlaps with the expression of two neuropeptides,
VIP and AVP. Sections stained with VPAC2R and AVP or VIP showed a clear overlap
with these two neuropeptides (Fig. 3). Notably, VPAC2R expression overlapped strongly
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Figure 1. VPAC2R expression existed in various brain areas with the strongest
expression in the SCN. (A and D) Vipr2-/- brain section shows little or no VPAC2R
immunoreactivity when it is stained it with the rabbit anti-VPAC2R antibody. (B, C, and
E) Brain sections of wild type mice exhibit a modest to strong signal of VPAC2R
expression. Note that the intense staining in the SCN (B, E), moderate to weak staining in
the cortex (B, C), indisium griseum (B), hippocampus (C), and arcuate nucleus (C). All
the sections were illuminated in the same intensity using a bright field microscope and
the slide scanner.
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Figure 2. VPAC2R expression broadly existed in the SCN. VPAC2R
immunoreactivity was present throughout the rostral to caudal axis of the SCN. Note that
stronger dorsomedial expression of VPAC2R than ventrolateral one in the medial SCN
(the second to the forth images from the left).
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with AVP cell bodies and VIP projections in the dorsomedial area. On the other hand, the
overlap between VPAC2R expression and VIP cell bodies in the ventrolateral area was
relatively weak. We also detected VPAC2R labeling in other areas that did not express
VIP or AVP in the SCN slice and in most of cells in dispersed SCN neuronal cultures.
Therefore, we concluded that VPAC2R is expressed in most, if not all, SCN cells.

VPAC2R was expressed primarily in dendrites and cell bodies.
To identify the role of VPAC2R in synaptic transmission, we examined the intracellular
localization of VPAC2R by staining dispersed SCN cultures in low density with VPAC2
antibody and either dendritic (MAP2) or axonal (Tau-1) antibody. VPAC2R mainly
overlapped with the dendritic marker on somata and dendrites of neurons, while it barely
overlapped with the axonal marker (Fig. 4). We confirmed a strong VPAC2R expression
in soma and dendrites, which receive synaptic transmission.

VPAC2R was detected throughout the day.
To examine whether VPAC2R expression is rhythmic, we collected the 2-3 brains from
mice housed in 12 h/12 h light/dark cycle (LD) or in constant darkness (DD) at 6
different time points over a circadian day and measured the SCN VPAC2R expression
level. The average pixel intensity of the VPAC2R staining in medial, bilateral SCN was
determined after subtracting the staining intensity of the brain area outside of the SCN.
The VPAC2R expression was not significantly different at day and night in LD (day:
ZT1-10, night: ZT12-22; p > 0.05, F1,15 = 0.64, One-way ANOVA, Schéffe post hoc)
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and DD (day: CT1-11, night: CT12-22; p > 0.05, F1,16 = 0.22, One-way ANOVA,
Schéffe post hoc; Fig. 5). We conclude that the SCN expresses VPAC2R constitutively.
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Figure 3. VPAC2R colocalized with VIP and AVP in the SCN. Repesentative images
of SCN stained for VPAC2R (A-D), and VIP (B) or AVP (E). The composite images
show the extensive overlap (yellow) between VPAC2R (green) and VIP (red), and AVP
(red) expression (C and F).
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Figure 4. VPAC2R colocalized with dendritic markers but not with axonal markers
in the SCN. Representative images of dissociated SCN neurons stained for VPAC2R (A
and D) and MAP2, a dendritic marker protein (B), or Tau-1, an axonal marker protein (E).
Note that VPAC2R (green) staining colocalizes with MAP2 (red) along cell body and
projections (C) but does not overlap with Tau-1 (red) staining (F).
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Figure 5. VPAC2R expression did not vary temporarily in either (A) 12h/ 12h LD or
(B) constant darkness. The average intensity of VPAC2R expression in bilateral SCN
was measured in medial SCN. Data points represent the mean ± SEM of 3 brains per
each time point. The result suggests that VPAC2R expression be not fluctuating between
day and night in LD (p > 0.05, F1,15 = 0.64, One way ANOVA, Scheffé post hoc) or in
DD (p > 0.05, F1,16 = 0.22, One way ANOVA, Scheffé post hoc).
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Discussion
VPAC2R delivers VIP-mediated signaling in various mouse brain areas.
Using a specific antibody against VPAC2R, we found weak to moderate staining
throughout the brain, and intensive staining in the SCN in wild type mice. We confirmed
the specificity with no staining of VPAC2R in the Vipr2-/- mice brains. The strongest
signal of the SCN is consistent to the previous results of intense Vipr2 mRNA throughout
the SCN (Usdin et al. 1994; Kalamatianos et al. 2004) and transgene expression of
VPAC2R (Kallo et al. 2004). Notably, the VPAC2R expression in the SCN heavily
overlaps with the immunoreactivity of VIP neurons and their projections.

In addition to the SCN, we also found the proximity of VPAC2R expression to the areas
of VIP expression. For instance, VIP cell bodies have been found in the retina, olfactory
bulb, and cerebral cortex (Staun-Olsen et al. 1985; Gall et al. 1986; Okamoto et al. 1992).
VIP projections have been observed in the lateral geniculate nucleus, hippocampus,
amygdala, and throughout the medial hypothalamus to paraventricular nucleus of the
thalamus (Abrahamson & Moore 2001; Heintz 2004). We confirmed the VPAC2R
expression in or near some of these areas. Also, we found VPAC2R expression in the
indusium griseum, hippocampus, midbrain, and cerebellum. The VIP application to these
areas is shown to have effects including the modulation of firing rates (Yang et al. 2009),
learning and memory (Gozes et al. 1993; Yamaguchi & Kobayashi 1994), and
neurotrophic action (Cavallaro et al. 1996), supporting our findings. We observed a fairly
intense expression in the arcuate nucleus, which confirms the role of VIP in
neuroendocrine and lactation (Harney et al. 1996; Smith et al. 2000; Gerhold et al. 2001).
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VPAC2R expression outside the SCN suggests the VIP-VPAC2R signaling in noncircadian functions or the influence of VIP projections from these areas.

Notably, some brain areas with high VIP-immunoreactivity expressed VPAC2R only
weakly. For instance, we saw low expression of VPAC2R in the BNST in spite of its
strong VIP immunoreactivity. This result indicates that some of the VIP signaling outside
of the SCN is received by other receptors including VPAC1R. Also, VPAC2R
immunoreactivity of the hypothalamus or thalamus was not as strong as the Vipr2 mRNA
signal (Usdin et al. 1994; Kalamatianos et al. 2004), which suggests post-translational
modification of VPAC2R expression. We did not observe any brain areas showing low
VIP and high VPAC2R staining, indicating the regionally restricted expression of
VPAC2R compared with VIP expression. These data suggest that VIP may use any
individual receptor or combination of different ones in the VIP/PACAP receptor family
outside of the SCN.

VPAC2R generates coupling among SCN cells.
We found VPAC2R expression in all SCN cells, including VIP-ergic and AVP-ergic
neurons. Since both VIP and AVP genes have CRE (Hahm et al. 1999; Kim et al. 2001),
and VIP signaling increases intracellular cAMP (Rea 1990; An et al. 2011), VPAC2Rmediated cAMP increase would facilitate the upregulation of both neuropeptides.
VPAC2R expression and VIP projections on AVP cells suggest the dorsomedial SCN
receives inputs from the ventrolateral SCN through VIP-VPAC2R signaling. Notably, the
dorsomedial SCN loses synchrony when it is separated from the ventrolateral SCN
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(Yamaguchi et al. 2003; Buhr et al. 2010). Therefore, VPAC2R may mediate coupling
among and autoregulation of the SCN neurons.

VPAC2R is similar to Drosophila PDFR.
These results share similarities with the studies of a synchronizing neuropeptide, pigment
dispersing factor and its receptor, Though VIP and PDF do not have a sequence
homology in their genes, they function similarly. Both neuropeptides are released to
generate robust rhythms and synchronize clock cells. PDF- or PDFR-null flies are
arrhythmic in constant conditions with desynchronized clock neurons (Renn et al. 1999;
Lin et al. 2004), which parallels in Vip-/- or Vipr2-/- animals (Harmar et al. 2002;
Colwell et al. 2003; Aton et al. 2005; Maywood et al. 2006). Both VPAC2R and PDFR
belong to the class B GPCR family, increasing intracellular cAMP level with the binding
to its ligand (Shafer et al. 2008; An et al. 2011). Like the VPAC2R expression in all SCN
neurons, PDFR is expressed in most of clock neurons including PDF-positive neurons in
the Drosophila brain (Shafer et al. 2008; Im & Taghert 2010). We conclude that both
VIP and PDF contribute the robustness of the oscillator by regulating and autoregulating
the output of clock cells.

VPAC2R integrates circadian timing inputs.
VPAC2R staining is present mainly along the cell body and dendrites. Therefore, a
VPAC2R-expressing cell would integrate inputs from multiple VIP cells and determine
the dominant circadian rhythms. As a class B of GPCR, VPAC2R activates adenylate
cyclase, protein kinase A, or phospholipase C and D, and in turn, increases cAMP and
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Ca2+ (Nielsen et al. 2002; Meyer-Spasche & Piggins 2004; Langer & Robberecht 2007;
An et al. 2011). These second messenger molecules would upregulate the activity of
various transcription factors (Ding et al. 1997), leading to the modulation of circadian
firing rates (Reed et al. 2002; Aton & Herzog 2005), inhibitory synaptic transmission (Itri
& Colwell 2003; Itri et al. 2004), and gene expression in the SCN (An et al. 2011).
Interestingly, Vipr2-/- animals lose circadian gene expression rhythms of c-FOS and pERK in the SCN. Based on these data, we conclude that VPAC2R functions to integrate
circadian timing information from VIP-ergic neurons for cyclic gene expression and
firing rates.

VPAC2R is expressed throughout the circadian day.
VIP entrains PER2 expression rhythm in SCN explant cultures with a stable phase
relation as predicted from the phase response curve (An et al. 2011). This raises the
possibility that cyclic VPAC2R abundance induces the differential response to VIP over
the circadian day. Diurnal variation of VPAC2R mRNA levels also supports this
possibility (Cagampang et al. 1998c; Shinohara et al. 1999). In contrast to the previous
results, we found that VPAC2R immunoreactivity does not oscillate in the SCN. This
result may be due to the post-translational modification of VPAC2R or too low amplitude
of VPAC2R rhythms. Alternatively, the receptor affinity to VIP or receptor regulation
such as phosphorylation could be rhythmic. Perhaps, oscillations in VPAC2R may not
need to be rhythmic. Rather, the rhythms in release of a synchronizing factor or
expression of downstream molecules may be sufficient to regulate the SCN functions.
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The constitutive expression of VPAC2R is somewhat consistent to our VIP PRC since
VIP shift PER2 gene expression rhythms throughout the day. The continuous expression
of VPAC2R would be beneficial based on our recent data, showing the constitutive
receptivity to VIP helps the SCN to recover from jet lag by VIP administration at any
time point. Taken together, we conclude that constitutive VPAC2R expression in all SCN
neurons mediates circadian synchrony among the SCN neurons.

Future directions
We found that various cell types in the SCN express VPAC2R throughout the circadian
day. Since our immunolabeling data disagreed with the mRNA data, we will find possible
mechanisms, which regulate properties of VPAC2R rhythmically. For instance, we will
measure VIP-induced VPAC2R internalization of dissociated SCN neurons plated in a
low density. Since surface VPAC2R levels may be regulated by the phosphorylation
(Langer & Robberecht 2007), we can measure the phosphorylation of VPAC2R using
Western blots at different time of the day, instead. Rhythmic variation in internalization
or phosphorylation of VPAC2R would indicate the circadian positioning of VPAC2R to
the membrane, which may be one of the underlying mechanisms of the time-dependent
phase shifts by VIP.

In addition, we found the strong VPAC2R staining in the dorsomedial SCN, and the
relatively weak staining in ventrolateral SCN. In the medial SCN, it was notable that the
moderate staining at the center was surrounded by a circle of strong VPAC2R
immunostaining. Interestingly, neurons in the center of the SCN exclusively express a
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neuropeptide, calbindin in hamster (Antle & Silver 2005), and it is possible that
calbindin-expressing neurons have weak VPAC2R expression. Also, we have not
quantified how much AVP-ergic and VIP-ergic neurons contribute to the VPAC2R
expressing populations. Since different neuropeptides have various functions inside and
of the output of the SCN (Antle & Silver 2005), it is worthwhile to characterize the
VPAC2R expression in different neuropeptidergic cells. We will count the cells
expressing different neuropeptides including AVP and VIP, besides, monitoring their
VPAC2R expression in dispersed SCN cultures.

Finally, we will identify the light-mediated regulations of VPAC2R. Since VIP release is
induced by the light in the SCN (Shinohara et al. 1993), VPAC2R expression may be
also regulated by light. Recently, it was shown that constant light causes arrhythmic
behavior and desynchrony among the SCN (Ohta et al. 2005), and now we have evidence
that VIP modulates these events. These results suggest that VIP or VPAC2R may be
depleted in constant light, phenocopying Vip-/- or Vipr2-/- mice. To test this possibility,
we will house mice in light tight chamber, collect their brains after two different light
protocols, a light pulse in constant darkness or the constant light, and measure their VIPor VPAC2R immunoreactivity in the SCN.

In summary, we screened several antibodies against VPAC2R, and discovered an
antibody specific to VPAC2R. Due to the lack of a specific antibody, the anatomical
characterization of VPAC2R has not been extensively studied. Using the antibody, we
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identified spatiotemporal expression of VPAC2R in SCN tissues and individual neurons,
and hope to examine the three possibilities near future.
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